Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,1.3794511582016428e-47,35.49222362337117,3829.6043154155914,"['RPL4', 'RPL5', 'RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPLP0', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS6KA6', 'RPS17', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPL22', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",7.545597835362986e-45,0,0,76
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,3.045182418282353e-24,9.667973311092577,523.506073253167,"['COX7B', 'NDUFA12', 'COX4I1', 'COX6A1', 'COX7C', 'ATP5IF1', 'UQCRFS1', 'COX8A', 'NDUFC2', 'NDUFC1', 'COX6B1', 'COX7A2L', 'NDUFS6', 'NDUFS5', 'NDUFS3', 'SLC25A5', 'SLC25A4', 'SLC25A6', 'NDUFB9', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'NDUFB4', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'UQCRH', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'COX11', 'NDUFV1', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA3', 'NDUFA1', 'COX6C', 'ATP5F1D', 'ATP5F1E', 'UQCRQ', 'ATP5PO']",8.3285739140022355e-22,0,0,57
3,Oxidative phosphorylation WP623,2.2966600713023843e-16,11.042355371900827,397.63417413813846,"['NDUFB9', 'NDUFB7', 'NDUFA11', 'NDUFB10', 'NDUFB5', 'NDUFB4', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'NDUFV1', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'ATP5PD', 'ATP6AP1', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA3', 'ATP6AP2', 'NDUFC2', 'NDUFC1', 'ATP5F1D', 'ATP5F1E', 'NDUFS6', 'NDUFS5', 'NDUFS3', 'ATP5PO']",4.187576863341348e-14,0,0,35
4,Nonalcoholic fatty liver disease WP4396,7.799492539091743e-13,3.8880583804895874,108.39730844329115,"['NDUFA13', 'COX7B', 'GSK3A', 'NDUFA11', 'NDUFA12', 'COX4I1', 'PRKAG1', 'COX6A1', 'COX7C', 'BBC3', 'AKT3', 'LEPR', 'UQCRFS1', 'RAC1', 'COX8A', 'NDUFC2', 'NDUFC1', 'COX6B1', 'COX7A2L', 'PIK3CA', 'NDUFS6', 'DDIT3', 'NDUFS5', 'NDUFS3', 'ATF4', 'NDUFB9', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'ADIPOR1', 'COX5B', 'UQCRH', 'CDC42', 'NDUFV1', 'NDUFA8', 'XBP1', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFA1', 'COX6C', 'NFKB1', 'UQCRQ', 'CYCS', 'BAX']",1.0665806047207959e-10,0,0,56
5,Mitochondrial complex I assembly model OXPHOS system WP4324,1.0743121463561072e-08,5.444764649375601,99.90598737370354,"['NDUFB9', 'NDUFA13', 'NDUFB7', 'DMAC1', 'NDUFB10', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'NDUFV1', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA3', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFS3', 'NDUFAF3', 'TMEM126B']",1.1752974881135814e-06,0,0,26
6,Mitochondrial CIV Assembly WP4922,6.138508875529868e-08,7.331091322470633,121.74082743910462,"['COX8A', 'COA3', 'COX7B', 'COX16', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'COX5B', 'COX6C', 'COX7C', 'PET117', 'COX6B1', 'TMEM177', 'SCO2', 'COX11', 'COX14']",5.596273924858063e-06,0,0,19
7,Photodynamic therapy-induced unfolded protein response WP3613,3.079211995053716e-05,5.914414414414415,61.44042586995079,"['XBP1', 'WARS', 'HSPA5', 'UBE2E1', 'PDIA6', 'HSP90B1', 'BBC3', 'NARS', 'DDIT3', 'DNAJB11', 'DNAJB9', 'CALR', 'ATF4']",0.0024061842304205464,0,0,13
8,Proteasome Degradation WP183,6.429282056417755e-05,3.151124420174975,30.41485012690799,"['UBE2B', 'H2AFZ', 'HLA-B', 'HLA-A', 'HLA-F', 'PSMB10', 'PSMA7', 'PSMD8', 'PSMB6', 'UCHL1', 'PSMC5', 'PSMD7', 'PSMB5', 'UBB', 'PSMC3', 'PSMB3', 'PSMD2', 'PSME3', 'PSMC1', 'UBC', 'PSME1', 'PSME2']",0.00439602160607564,0,0,22
9,Mitochondrial complex III assembly WP4921,0.00019088324144535355,7.497547015535568,64.20785764867173,"['UQCRB', 'UQCC3', 'UQCC2', 'UQCRQ', 'LYRM7', 'UQCRFS1', 'UQCR11', 'UQCR10', 'UQCRH']",0.011601459230067598,0,0,9
10,Translation Factors WP107,0.0003412536704958898,2.9736247947454846,23.73810315043646,"['EIF4A2', 'EIF2B2', 'EIF1AX', 'EIF2S2', 'EEF2', 'EIF1', 'EEF1B2', 'EEF1G', 'EEF1A1', 'EIF5', 'EIF2S3', 'EIF3I', 'EIF3J', 'EIF4H', 'EIF3F', 'EIF3D', 'EIF4G3', 'EIF4B', 'EIF4G1']",0.018666575776125172,0,0,19
11,7q11.23 copy number variation syndrome WP4932,0.0004365641483130017,2.3018906158179497,17.808749927082726,"['PCNA', 'ATP5MC2', 'ATP5MC3', 'DDX21', 'UBE2L6', 'ACACB', 'FBLN5', 'ATP5MC1', 'GRIP1', 'ATP5F1A', 'ATP5F1B', 'NUP62', 'EIF4H', 'PRKG1', 'MAPK3', 'ATP5PB', 'UBE2E1', 'VPS37C', 'HSPA2', 'ATP5F1D', 'ATP5F1E', 'DNAJC30', 'ATP5PO', 'SQSTM1', 'GAPDH', 'VAMP2', 'ATF4', 'FBN1']",0.021709144466110174,0,0,28
12,Cellular Proteostasis WP4918,0.0006717855067598406,24.961224489795917,182.35600910853975,"['VBP1', 'PFDN1', 'PFDN2', 'PFDN4', 'PFDN5']",0.028307483763326913,0,0,5
13,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.0006727555556183726,5.622240392477514,41.065566342560466,"['EIF5', 'EIF2S3', 'EIF1AX', 'EIF3I', 'EIF3J', 'EIF3F', 'EIF2S2', 'EIF3D', 'EIF1']",0.028307483763326913,0,0,9
14,Pyrimidine metabolism WP4022,0.0012572128312416078,2.2686215005859847,15.151800964530478,"['DTYMK', 'POLR3GL', 'NME2', 'CTPS1', 'NME1', 'POLE4', 'POLD4', 'ZNRD1', 'RRM2B', 'NME7', 'POLR2C', 'POLR2D', 'POLD2', 'POLE3', 'POLR2E', 'POLR1E', 'CMPK2', 'TK2', 'POLR2G', 'POLR2I', 'DCTPP1', 'POLR3K', 'POLR2K', 'POLR2L']",0.04812163506755561,0,0,24
15,VEGFA-VEGFR2 Signaling Pathway WP3888,0.0013196060804631336,1.484413399099094,9.84228727453192,"['RPL5', 'FHOD1', 'LDB2', 'RPL10A', 'RPL7', 'ACTG1', 'PPP3CA', 'RPL18A', 'CCND1', 'TMSB4X', 'RACK1', 'RPLP2', 'ELOC', 'RAC1', 'ATP6V1E1', 'ACP1', 'HRAS', 'PRKG1', 'HSP90AA1', 'SSR4', 'TPM3', 'IGFBP3', 'SSR3', 'GAB1', 'SHROOM2', 'SARS', 'RPL13A', 'PDIA6', 'SND1', 'EPN1', 'RCN1', 'PIK3CA', 'KATNAL2', 'NCL', 'FSCN1', 'TFAM', 'RPL27', 'PRKD1', 'RPL26', 'TKT', 'ATP6V0D1', 'ALDOA', 'GAPDH', 'PTMA', 'VCL', 'ATF4', 'LRRC59', 'SET', 'ROCK2', 'EPB41', 'PXN', 'TXN', 'ACACB', 'CDC42', 'STIP1', 'LDHA', 'RAP1A', 'FXR2', 'AP2S1', 'PGK1', 'DNAJB9', 'RICTOR', 'ASCC3', 'FADD', 'CCT7', 'ABCF2', 'TXNDC5', 'MAPK3', 'SDF2L1', 'STAT1', 'NFKB1', 'QKI', 'DNAJA1', 'NFKBIA', 'AFDN', 'BMP2', 'CYCS', 'HYOU1', 'TPP1', 'P4HB', 'EIF3F', 'CALR', 'GRSF1', 'EIF3D', 'EIF4G2', 'EIF4G1']",0.04812163506755561,0,0,86
16,16p11.2 proximal deletion syndrome WP4949,0.002283842783657657,2.2856096602479368,13.900839846430644,"['CCT3', 'CCT2', 'PCNA', 'IGFBP3', 'QPRT', 'KIF22', 'SEZ6L2', 'NFKB1', 'CCT6A', 'PPP4R1', 'HIRIP3', 'PPP4R4', 'TCP1', 'TMEM219', 'PPARG', 'ALDOA', 'CCT7', 'CDIPT', 'CCT5', 'CCT4', 'MAPK3']",0.07807887516629615,0,0,21
17,Selenium Micronutrient Network WP15,0.003549612707671048,2.4299660142974333,13.707236059721177,"['GPX4', 'TXNRD2', 'APOA1', 'TXN', 'SELENOK', 'NFKB1', 'SELENOH', 'SOD1', 'SELENOM', 'PRDX4', 'SELENOS', 'FLAD1', 'PRDX1', 'SELENOW', 'PNPO', 'SEPHS2', 'MSRB1']",0.11421400888800372,0,0,17
18,RalA downstream regulated genes WP2290,0.0046626180020256655,5.991180073499388,32.16172217648301,"['CDC42', 'RALBP1', 'RAC3', 'RAC1', 'HRAS', 'EXOC2']",0.14169178039489105,0,0,6
19,Methionine De Novo and Salvage Pathway WP3580,0.005408755497494658,3.9957498978340826,20.856760587730626,"['AHCY', 'ADI1', 'AMD1', 'ODC1', 'MSRB2', 'TXN', 'MAT2B', 'SRM']",0.15571522405945146,0,0,8
20,Exercise-induced Circadian Regulation WP410,0.00615189934048684,2.419553146483342,12.317931541006098,"['DAZAP2', 'HSPA8', 'GSTM3', 'BTG1', 'GSTP1', 'G0S2', 'QKI', 'DNAJA1', 'SUMO1', 'STBD1', 'CRY2', 'CRY1', 'TAB2', 'ERC2', 'EIF4G2']",0.1682544469623151,0,0,15
21,Synaptic Vesicle Pathway WP2267,0.009466301851160376,2.2725409836065573,10.590079526071865,"['RAB3A', 'SLC32A1', 'SYT1', 'STXBP1', 'CLTA', 'SYP', 'AP2B1', 'SYN3', 'CPLX2', 'CPLX3', 'DNM3', 'AP2S1', 'SLC25A4', 'AP2M1', 'VAMP2']",0.24657462440879646,0,0,15
22,Cori Cycle WP1946,0.0128055962791973,4.278714344047133,18.646093690214606,"['LDHA', 'PGAM1', 'PGK1', 'TALDO1', 'ALDOA', 'GAPDH']",0.3183936893054965,0,0,6
23,Base Excision Repair WP4752,0.019976795271103916,2.4973415132924335,9.772556641247276,"['POLE4', 'POLD4', 'FEN1', 'PCNA', 'NEIL2', 'NTHL1', 'APEX1', 'POLD2', 'POLE3', 'APEX2']",0.47510030492581923,0,0,10
24,Ciliary landscape WP4352,0.02368948174887316,1.4360942992309116,5.374904797339091,"['ECHS1', 'VPS4A', 'COPS7A', 'MYL6B', 'SMC4', 'EHBP1', 'RPGR', 'PSMD8', 'PSMD7', 'PGRMC2', 'RMND5A', 'APMAP', 'ARHGDIA', 'BBS9', 'TMED1', 'SNRPB2', 'RAC1', 'IFT57', 'DCAF11', 'NUDC', 'DYNLT1', 'NDUFA5', 'H3F3A', 'LCA5', 'DYNLL1', 'COX6C', 'DYNLL2', 'LSM4', 'NFKB1', 'AIMP1', 'MKLN1', 'MYL6', 'COPS6', 'TBC1D4', 'RAB14', 'MFAP1', 'WNK1', 'GID8', 'TIPRL', 'CD2BP2', 'MCM4', 'MCM6', 'CALM1', 'COPS8', 'EXOC2']",0.5399227715264008,0,0,45
25,Computational Model of Aerobic Glycolysis WP4629,0.024750820155021468,4.158503401360544,15.3818743125315,"['LDHA', 'PGK1', 'ALDOA', 'GAPDH', 'PFKM']",0.5415479449918696,0,0,5
26,IL-18 signaling pathway WP4754,0.03207999846088303,1.4257341434226272,4.90384472799746,"['MTCH1', 'PIGT', 'CD83', 'EPB41', 'CD81', 'RGS16', 'COX17', 'KLC1', 'RND2', 'ACACB', 'CENPB', 'RXRB', 'TMSB4X', 'STMN1', 'FADD', 'B2M', 'ABCF1', 'MAPK3', 'IMP3', 'HPS1', 'NDUFC1', 'BPGM', 'EEF2', 'RUNX2', 'NFKB1', 'ARFGAP2', 'NFKBIA', 'SLC4A7', 'ARL4D', 'BMP2', 'NACA', 'SYT10', 'RFX5', 'ZNF219', 'CYCS', 'BAX', 'HDGF', 'LTB', 'NFKBIE', 'AARS', 'ITM2C']",0.674913813773193,0,0,41
27,Proximal tubule transport WP4917,0.035086782012945274,2.1129610978219815,7.078273461350222,"['ATP6V1A', 'ATP6V1G1', 'FXYD2', 'SLC3A2', 'ATP1A1', 'ATP6V1E1', 'SLC4A4', 'ATP6V0C', 'ATP6V1D', 'ATP6V1C1', 'ATP6V1F']",0.6958812769827444,0,0,11
28,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.037562532219995545,2.687688536953243,8.820317042272558,"['NFKBIA', 'PPP3CA', 'GSK3A', 'RASA1', 'DYRK1A', 'CALM1', 'NFKB1']",0.6958812769827444,0,0,7
29,Myometrial relaxation and contraction pathways WP289,0.037578472660737605,1.5111637812585876,4.958617874821723,"['RYR2', 'CAMK2D', 'RGS14', 'YWHAB', 'RGS16', 'ITPR1', 'ADCY8', 'ACTG1', 'RGS4', 'RGS2', 'GNG3', 'YWHAQ', 'GNG4', 'PRKACA', 'RGS7', 'GSTO1', 'IGFBP3', 'PDE4D', 'NFKB1', 'CREB3', 'PRKAR1A', 'GNB1', 'CRH', 'CALM3', 'PRKD1', 'GNB5', 'ATF5', 'CALM1', 'ATF4']",0.6958812769827444,0,0,29
30,Eukaryotic Transcription Initiation WP405,0.0381653351178836,1.9978714695047073,6.524703852301947,"['GTF2A2', 'TAF13', 'POLR2C', 'POLR2E', 'ILK', 'POLR1E', 'TAF7', 'POLR2G', 'POLR2I', 'GTF2H3', 'POLR3K', 'POLR2K']",0.6958812769827444,0,0,12
31,Glycolysis and Gluconeogenesis WP534,0.0418343549825572,2.2466884709730173,7.131073204894967,"['LDHA', 'MDH2', 'PGAM1', 'PGK1', 'ENO2', 'ALDOA', 'PFKM', 'GAPDH', 'GCK']",0.7381739411438318,0,0,9
32,Androgen receptor signaling pathway WP138,0.0476468288999157,1.6122408425515002,4.9075631020003945,"['NCOA1', 'NCOA2', 'ROCK2', 'NCOA3', 'DSTN', 'RNF4', 'RUNX2', 'RHOB', 'CDC42', 'CCND1', 'SUMO1', 'KAT5', 'PRDX1', 'BAG1', 'RACK1', 'RAC1', 'CALR', 'FKBP4', 'PLPP1', 'RAN']",0.8052518853025109,0,0,20
33,Metabolic reprogramming in colon cancer WP4290,0.05017529499447425,1.9617138180967968,5.869903852026946,"['LDHA', 'MDH2', 'PGAM1', 'PGK1', 'PYCR1', 'TALDO1', 'PYCR2', 'PDHB', 'TKT', 'GAPDH', 'GLS']",0.8052518853025109,0,0,11
34,Melanoma WP4685,0.05174652646585251,1.7007319009360307,5.036543999834333,"['GADD45A', 'MITF', 'BRAF', 'CDK6', 'CCND1', 'PIK3CA', 'ERBB4', 'AKT3', 'NF1', 'BAX', 'CALM3', 'RAC1', 'CALM1', 'HRAS', 'VCL', 'MAPK3']",0.8052518853025109,0,0,16
35,Apoptosis Modulation and Signaling WP1772,0.05246709306852355,1.6654361498496035,4.9089881409802905,"['HRK', 'TNFRSF6B', 'TRADD', 'PTPN13', 'NFKB1', 'BBC3', 'NFKBIA', 'TOLLIP', 'PEA15', 'MADD', 'CYCS', 'BAX', 'BIRC6', 'PRKD1', 'FADD', 'BCL2L2', 'MAPK3']",0.8052518853025109,0,0,17
36,Cytosolic DNA-sensing pathway WP4655,0.05299646777128043,1.872697503069996,5.501105121429386,"['NFKBIA', 'POLR3GL', 'TRADD', 'POLR2E', 'ADAR', 'ISG15', 'FADD', 'POLR3K', 'POLR2K', 'NFKB1', 'POLR2L', 'NFKBIB']",0.8052518853025109,0,0,12
37,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.06117253499696087,2.328948801742919,6.507215620062397,"['ADAMTS2', 'CRTAP', 'BMP1', 'ITPR1', 'PLOD2', 'P4HB', 'PPIB']",0.8561124165448092,0,0,7
38,Peroxiredoxin 2 induced ovarian failure WP4873,0.06271855015235077,4.987357259380098,13.810481108992409,"['MAPK10', 'STAR', 'BAX']",0.8561124165448092,0,0,3
39,mRNA Processing WP411,0.06507352816398866,1.4284537053387485,3.9028747034483877,"['SF3B5', 'DHX8', 'RNMT', 'CSTF2T', 'SNU13', 'YBX1', 'SNRPD1', 'SNRPB2', 'SNRPD3', 'TXNL4A', 'HNRNPA1', 'SF3A1', 'PRMT2', 'NCBP2', 'PRMT1', 'SUPT5H', 'LSM2', 'PRPF4', 'LSM7', 'PHF5A', 'SNRPG', 'CD2BP2', 'SNRPE', 'HNRNPH2', 'SNRPF', 'DNAJC8', 'SNRPB', 'SRSF9']",0.8561124165448092,0,0,28
40,Nucleotide metabolism WP404,0.06593253727772515,2.494895875867701,6.7839293129898115,"['PRPS1', 'RRM2B', 'MTHFD2', 'NME2', 'OAZ1', 'SRM']",0.8561124165448092,0,0,6
41,Purine metabolism and related disorders WP4224,0.06593253727772515,2.494895875867701,6.7839293129898115,"['PRPS1', 'GRM5', 'RRM2B', 'PFAS', 'ITPA', 'APRT']",0.8561124165448092,0,0,6
42,"Relationship between inflammation, COX-2 and EGFR WP4483",0.06593253727772515,2.494895875867701,6.7839293129898115,"['PIK3CA', 'PTGES2', 'AKT3', 'BRAF', 'HRAS', 'MAPK3']",0.8561124165448092,0,0,6
43,Fragile X Syndrome  WP4549,0.06729951354922632,1.4440876446640136,3.8970181966223976,"['CYFIP2', 'ITPR1', 'CLTA', 'AKAP5', 'SLC6A1', 'GRIP1', 'PPP3CA', 'GRM5', 'AP2S1', 'PRKACA', 'AP2M1', 'NTRK2', 'DUSP3', 'KCND2', 'GAB1', 'PPP2R5B', 'BRAF', 'AP2B1', 'EEF1A1', 'ARHGAP32', 'ALDH5A1', 'PRKAR1A', 'NF1', 'PLCB1', 'EIF4G1', 'HCN1']",0.8561124165448092,0,0,26
44,Ras signaling WP4223,0.07055809008935483,1.3794241962799039,3.657293491745264,"['RAB5C', 'RASAL2', 'IGF1R', 'CDC42', 'GNG10', 'GNG3', 'RAP1A', 'GNG4', 'AKT3', 'RAC3', 'RAC1', 'PRKACA', 'HRAS', 'MAPK3', 'NTRK2', 'RALBP1', 'PLA2G4C', 'GAB1', 'NFKB1', 'MAPK10', 'AFDN', 'MRAS', 'PIK3CA', 'RASA1', 'GNB1', 'NF1', 'CALM3', 'GNB5', 'RGL1', 'CALM1', 'FGFR2', 'EXOC2']",0.8771653472472066,0,0,32
45,Gastric acid production WP2596,0.07446195061770251,9.972278842234,25.902665347385366,"['CCK', 'VIP']",0.8814035392256759,0,0,2
46,Nanomaterial-induced inflammasome activation WP3890,0.07446195061770251,9.972278842234,25.902665347385366,"['NFKB1', 'CTSB']",0.8814035392256759,0,0,2
47,Cell migration and invasion through p75NTR WP4561,0.07573302805046941,2.1832107843137254,5.633864748081179,"['NTRK2', 'ARF1', 'TRIO', 'EFNB3', 'AKT3', 'RAC1', 'EFNA5']",0.8814035392256759,0,0,7
48,Genotoxicity pathway WP4286,0.08180322024871975,1.711759546225367,4.285285039715908,"['MEX3B', 'RPS27', 'RRM2B', 'GADD45A', 'EI24', 'BLOC1S2', 'SEL1L', 'PCDH8', 'ITPR1', 'RAPGEF2', 'CBLB', 'TRIAP1']",0.8955169171283511,0,0,12
49,GABA receptor Signaling WP4159,0.0824681845799645,1.9962402942378423,4.981303648617238,"['GABRB1', 'GABBR1', 'SLC32A1', 'GABRA4', 'AP2S1', 'AP2B1', 'SLC6A1', 'AP2M1']",0.8955169171283511,0,0,8
50,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.0824681845799645,1.9962402942378423,4.981303648617238,"['CREB3', 'CAMK2D', 'STAR', 'ITPR1', 'CALM3', 'CALM1', 'CAMK1G', 'ATF4']",0.8955169171283511,0,0,8
51,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.08349426466827406,1.593782699686083,3.957326321975838,"['HSPA9', 'HSPA8', 'HSPA5', 'UBE2L6', 'HSPA2', 'HSPA14', 'PSMD8', 'PSMC5', 'TUBA1A', 'PSMD7', 'TUBB2A', 'PSMC3', 'PSMD2', 'RNF19A', 'PSMC1']",0.8955169171283511,0,0,15
52,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.09057449294480514,2.494285714285714,5.990233271619109,"['TJP1', 'PXN', 'ITPR1', 'VCL', 'MAPK3']",0.9054485100617825,0,0,5
53,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.09210202180955204,1.7159369885433715,4.092266712912369,"['PPP1R2', 'PPP1R3F', 'XBP1', 'MAP1LC3A', 'PPP1R11', 'HSPA5', 'PPP1R7', 'PPP1R3E', 'DDIT3', 'PPP1R8', 'ATF4']",0.9054485100617825,0,0,11
54,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.09632491043478027,2.8501486273824095,6.669428499420325,"['GALNT3', 'CCND1', 'NFKB1', 'FGFR2']",0.9054485100617825,0,0,4
55,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.09632491043478027,2.8501486273824095,6.669428499420325,"['SFRP1', 'CCND1', 'NRG3', 'ERBB4']",0.9054485100617825,0,0,4
56,Dual hijack model of Vif in HIV infection WP3300,0.09641467780503667,3.7402120717781404,8.748718199006616,"['UBB', 'ELOB', 'ELOC']",0.9054485100617825,0,0,3
57,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.09641467780503667,3.7402120717781404,8.748718199006616,"['AHCY', 'MAT2B', 'CDO1']",0.9054485100617825,0,0,3
58,Pentose Phosphate Metabolism WP134,0.09641467780503667,3.7402120717781404,8.748718199006616,"['TALDO1', 'PGLS', 'TKT']",0.9054485100617825,0,0,3
59,Chemokine signaling pathway WP3929,0.09766263636863834,1.39431567064946,3.2435076226167,"['VAV3', 'ROCK2', 'STAT1', 'PXN', 'BRAF', 'ADCY8', 'CXCL14', 'NFKB1', 'GNAI2', 'NFKBIA', 'CDC42', 'GNG10', 'GNG3', 'RAP1A', 'PIK3CA', 'GNG4', 'AKT3', 'GNB1', 'GNB5', 'RAC1', 'PLCB1', 'HRAS', 'NFKBIB', 'MAPK3']",0.9054485100617825,0,0,24
60,Aryl Hydrocarbon Receptor Pathway WP2873,0.11037199602489882,1.9403140885984023,4.276255962327598,"['NCOA1', 'HSP90AA1', 'CDKN1B', 'PTGES3', 'CDC37', 'AIP', 'BAX']",0.9997592994748913,0,0,7
61,Pregnane X receptor pathway WP2876,0.11438440660325688,2.26734693877551,4.916040127417228,"['NCOA1', 'NCOA2', 'HSP90AA1', 'PSMC5', 'NCOA3']",0.9997592994748913,0,0,5
62,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.12613528215490544,2.493676050591595,5.162907593632802,"['RYR2', 'ITPR1', 'CCK', 'PLCB1']",0.9997592994748913,0,0,4
63,Resistin as a regulator of inflammation WP4481,0.1303518570944824,1.8380417956656347,3.745043044396432,"['NFKBIA', 'PIK3CA', 'AKT3', 'ITPR1', 'PLCB1', 'NFKB1', 'MAPK3']",0.9997592994748913,0,0,7
64,G Protein Signaling Pathways WP35,0.1313945548643246,1.4042880590890439,2.8500736914040656,"['PDE4D', 'ITPR1', 'AKAP6', 'AKAP5', 'ADCY8', 'GNAI2', 'PPP3CA', 'GNG10', 'GNG3', 'GNAL', 'PRKAR1A', 'GNG4', 'GNB1', 'PRKD1', 'GNB5', 'PRKACA', 'CALM1', 'HRAS']",0.9997592994748913,0,0,18
65,Robo4 and VEGF Signaling Pathways Crosstalk WP3943,0.13259873724580573,4.985731757032205,10.073310667874985,"['SLIT2', 'RAC1']",0.9997592994748913,0,0,2
66,Vitamin B6-dependent and responsive disorders WP4228,0.13259873724580573,4.985731757032205,10.073310667874985,"['PNPO', 'PIGV']",0.9997592994748913,0,0,2
67,Canonical NF-KB pathway WP4562,0.13570970674938915,2.991924959216966,5.975583779548014,"['NFKBIA', 'NFKBIE', 'NFKB1']",0.9997592994748913,0,0,3
68,Heme Biosynthesis WP561,0.13570970674938915,2.991924959216966,5.975583779548014,"['ALAD', 'UROD', 'UROS']",0.9997592994748913,0,0,3
69,HIF1A and PPARG regulation of glycolysis WP2456,0.13570970674938915,2.991924959216966,5.975583779548014,"['LDHA', 'PPARG', 'GAPDH']",0.9997592994748913,0,0,3
70,Leptin and adiponectin WP3934,0.13570970674938915,2.991924959216966,5.975583779548014,"['PRKAG1', 'LEPR', 'ADIPOR1']",0.9997592994748913,0,0,3
71,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.13570970674938915,2.991924959216966,5.975583779548014,"['CAMK2D', 'CCND2', 'MEF2D']",0.9997592994748913,0,0,3
72,Head and Neck Squamous Cell Carcinoma WP4674,0.1401355092775189,1.4399432534678436,2.8296978623941262,"['GAB1', 'KEAP1', 'NFKB1', 'IGF1R', 'CDK6', 'CCND1', 'PIK3CA', 'SESN1', 'SESN2', 'AKT3', 'FAT1', 'RICTOR', 'FADD', 'HRAS', 'FGFR2']",0.9997592994748913,0,0,15
73,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.14082941528304338,2.078231292517007,4.073761327850809,"['RAB5C', 'MRAS', 'BRAF', 'HRAS', 'MAPK3']",0.9997592994748913,0,0,5
74,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.14293598737336227,1.4558241157995357,2.832099657582163,"['CDKN1B', 'STAT1', 'PDE4D', 'BRAF', 'IGF1R', 'GNAI2', 'MYL12B', 'RAP1A', 'PIK3CA', 'APEX1', 'GNB1', 'PLCB1', 'HRAS', 'MAPK3']",0.9997592994748913,0,0,14
75,Signal Transduction of S1P Receptor WP26,0.1483631688342017,1.8705594120049,3.5691997628927283,"['ASAH1', 'AKT3', 'MAPK6', 'PLCB1', 'GNAI2', 'MAPK3']",0.9997592994748913,0,0,6
76,DNA Repair Pathways Full Network WP4946,0.15230086165408416,1.3027381825335789,2.4516195484176504,"['XRCC6', 'FEN1', 'MRE11', 'PCNA', 'CENPX', 'CETN2', 'REV1', 'APEX2', 'FANCC', 'RAD23A', 'GTF2H3', 'GTF2H5', 'FANCF', 'DDB1', 'POLE4', 'POLD4', 'NEIL2', 'RAP1A', 'NTHL1', 'APEX1', 'POLD2', 'POLE3', 'REV3L', 'USP1']",0.9997592994748913,0,0,24
77,PPAR signaling pathway WP3942,0.16722320837006105,1.483445393019861,2.653031986951866,"['RXRB', 'ACADL', 'FABP5', 'ACOX1', 'FABP6', 'ME1', 'ILK', 'APOA1', 'PPARG', 'CPT1B', 'SLC27A5']",0.9997592994748913,0,0,11
78,Rett syndrome causing genes WP4312,0.16722320837006105,1.483445393019861,2.653031986951866,"['XAB2', 'EIF2B2', 'CDKL5', 'STXBP1', 'SCN8A', 'IMPDH2', 'BRAF', 'HIVEP2', 'SMARCA1', 'SCN2A', 'SCN1A']",0.9997592994748913,0,0,11
79,TNF-alpha signaling pathway WP231,0.1723826763346324,1.3468820396630077,2.367870360947589,"['HSP90AA1', 'TRADD', 'TXN', 'NFKB1', 'NFKBIA', 'PSMD2', 'CDC37', 'MADD', 'BAX', 'TAB2', 'RAC1', 'FADD', 'NFKBIE', 'HRAS', 'SKP1', 'MAPK3', 'NFKBIB']",0.9997592994748913,0,0,17
80,PDGF Pathway WP2526,0.17267996818491096,1.548298418247949,2.719300189381149,"['CDC42', 'NFKBIA', 'STAT1', 'RASA1', 'ARFIP2', 'RAC1', 'HRAS', 'NFKB1', 'MAPK3']",0.9997592994748913,0,0,9
81,Disruption of postsynaptic signaling by CNV WP4875,0.17448214010160323,1.596338373518594,2.7870996723944734,"['TJP1', 'RYR2', 'CAMK2D', 'DLG1', 'DLG2', 'NRXN3', 'DLGAP1', 'MAPK3']",0.9997592994748913,0,0,8
82,Oxidative Damage WP3941,0.17448214010160323,1.596338373518594,2.7870996723944734,"['CDC42', 'MAPK10', 'PCNA', 'CDKN1B', 'GADD45A', 'CYCS', 'NFKBIE', 'NFKB1']",0.9997592994748913,0,0,8
83,p38 MAPK Signaling Pathway WP400,0.17448214010160323,1.596338373518594,2.7870996723944734,"['CDC42', 'STAT1', 'TRADD', 'DDIT3', 'RAC1', 'HRAS', 'MEF2D', 'HMGN1']",0.9997592994748913,0,0,8
84,Purine metabolism WP4792,0.17935123246561516,2.4930668841761827,4.284109077914783,"['PRPS1', 'ITPA', 'APRT']",0.9997592994748913,0,0,3
85,DNA damage response WP707,0.18071244631194902,1.4256476229460266,2.4390666773049943,"['CDKN1B', 'MRE11', 'CCND2', 'CDK6', 'CCND1', 'RRM2B', 'GADD45A', 'SESN1', 'CYCS', 'BAX', 'ATRIP', 'BBC3']",0.9997592994748913,0,0,12
86,Senescence and Autophagy in Cancer WP615,0.18618621492683093,1.325728055783429,2.228559402066035,"['GABARAPL2', 'GABARAPL1', 'SPARC', 'CDKN1B', 'PCNA', 'IGFBP3', 'BRAF', 'CXCL14', 'GABARAP', 'IGF1R', 'RSL1D1', 'BMP2', 'MAP1LC3B', 'MAP1LC3A', 'SLC39A1', 'SQSTM1', 'HRAS']",0.9997592994748913,0,0,17
87,Nucleotide Excision Repair WP4753,0.18930325157979083,1.4673403103572717,2.4422486139014685,"['POLE4', 'DDB1', 'POLD4', 'PCNA', 'CETN2', 'POLD2', 'POLE3', 'RAD23A', 'GTF2H3', 'GTF2H5']",0.9997592994748913,0,0,10
88,TP53 network WP1742,0.19509600292024848,1.9946144430844552,3.2597256186069417,"['SUMO1', 'GADD45A', 'BAX', 'BBC3']",0.9997592994748913,0,0,4
89,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.19716439768456998,3.3235493952982744,5.396504957106734,"['COX8A', 'GSTP1']",0.9997592994748913,0,0,2
90,EV release from cardiac cells and their functional effects WP3297,0.19716439768456998,3.3235493952982744,5.396504957106734,"['ERBB4', 'RGS16']",0.9997592994748913,0,0,2
91,Metastatic brain tumor WP2249,0.19716439768456998,3.3235493952982744,5.396504957106734,"['CDC42', 'CDK6']",0.9997592994748913,0,0,2
92,miR-517 relationship with ARCN1 and USP1 WP3596,0.19716439768456998,3.3235493952982744,5.396504957106734,"['USP1', 'ARCN1']",0.9997592994748913,0,0,2
93,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.19716439768456998,3.3235493952982744,5.396504957106734,"['RIPPLY2', 'DLL3']",0.9997592994748913,0,0,2
94,The alternative pathway of fetal androgen synthesis WP4524,0.19716439768456998,3.3235493952982744,5.396504957106734,"['STAR', 'HSD17B6']",0.9997592994748913,0,0,2
95,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.20048698048812225,1.7810495626822158,2.8621572793218655,"['H3F3B', 'H2AFJ', 'H2AFZ', 'H3F3A', 'MAPK3']",0.9997592994748913,0,0,5
96,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.20048698048812225,1.7810495626822158,2.8621572793218655,"['LDHA', 'PRKAG1', 'KEAP1', 'PDHB', 'ACACB']",0.9997592994748913,0,0,5
97,Calcium Regulation in the Cardiac Cell WP536,0.202356306382441,1.2356883836531802,1.9742905223412628,"['RYR2', 'CAMK2D', 'CHRM1', 'RGS14', 'YWHAB', 'RGS16', 'ITPR1', 'ADCY8', 'GNAI2', 'RGS4', 'RGS2', 'GNG3', 'YWHAQ', 'GNG4', 'PRKACA', 'RGS7', 'ATP1B2', 'PRKAR1A', 'FXYD2', 'GNB1', 'CALM3', 'PRKD1', 'CALR', 'GNB5', 'CALM1']",0.9997592994748913,0,0,25
98,Regulation of Microtubule Cytoskeleton WP2038,0.21492351761247042,1.448170812122491,2.2265235898987967,"['CDC42', 'TRIO', 'PIK3CA', 'CFL2', 'DPYSL2', 'STMN1', 'TPPP', 'RAC1', 'PRKACA']",0.9997592994748913,0,0,9
99,Splicing factor NOVA regulated synaptic proteins WP4148,0.21492351761247042,1.448170812122491,2.2265235898987967,"['NTNG1', 'CDH2', 'CADM1', 'EPB41', 'APLP2', 'CLSTN1', 'EPB41L3', 'ANK3', 'EFNA5']",0.9997592994748913,0,0,9
100,Pancreatic adenocarcinoma pathway WP4263,0.2153484184879798,1.2853431774678699,1.9736418929988513,"['RALBP1', 'STAT1', 'GADD45A', 'PEBP1', 'BRAF', 'NFKB1', 'CDC42', 'MAPK10', 'CDK6', 'CCND1', 'PIK3CA', 'AKT3', 'RAC3', 'BAX', 'RAC1', 'ARHGEF6', 'MAPK3']",0.9997592994748913,0,0,17
101,miRNA regulation of DNA damage response WP1530,0.21642192710691718,1.3606221858370855,2.08246682937936,"['CDKN1B', 'MRE11', 'CCND2', 'CDK6', 'CCND1', 'RRM2B', 'GADD45A', 'SESN1', 'CYCS', 'BAX', 'ATRIP', 'BBC3']",0.9997592994748913,0,0,12
102,G1 to S cell cycle control WP45,0.2231859760580064,1.3718494271685762,2.0574310161478273,"['CDKN2D', 'CREB3', 'CDKN1B', 'CCND2', 'PCNA', 'CDK6', 'CCND1', 'GADD45A', 'CCNG2', 'MCM4', 'MCM6']",0.9997592994748913,0,0,11
103,Toll-like Receptor Signaling Pathway WP75,0.2276719879941783,1.3235972521686807,1.9587245134631692,"['STAT1', 'NFKB1', 'NFKBIA', 'MAPK10', 'PIK3CA', 'TOLLIP', 'AKT3', 'TAB2', 'FADD', 'RAC1', 'IFNAR1', 'NFKBIB', 'MAPK3']",0.9997592994748913,0,0,13
104,Apoptosis WP254,0.24602467766468636,1.297018837018837,1.818839907378035,"['HRK', 'TRADD', 'NFKB1', 'IGF1R', 'BBC3', 'NFKBIA', 'MAPK10', 'CYCS', 'BAX', 'FADD', 'NFKBIE', 'BCL2L2', 'NFKBIB']",0.9997592994748913,0,0,13
105,Endochondral Ossification with Skeletal Dysplasias WP4808,0.2517961933055358,1.3480351517161333,1.8591228302310456,"['GHR', 'THRA', 'STAT1', 'SOX6', 'PRKACA', 'CALM1', 'SLC38A2', 'GLI3', 'RUNX2', 'IGF1R']",0.9997592994748913,0,0,10
106,Endochondral Ossification WP474,0.2517961933055358,1.3480351517161333,1.8591228302310456,"['GHR', 'THRA', 'STAT1', 'SOX6', 'PRKACA', 'CALM1', 'SLC38A2', 'GLI3', 'RUNX2', 'IGF1R']",0.9997592994748913,0,0,10
107,Pilocytic astrocytoma WP2253,0.26438732487796024,2.4924582144313088,3.3158171385080513,"['NF1', 'BRAF']",0.9997592994748913,0,0,2
108,Role of Altered Glycolysation of MUC1 in Tumour Microenvironment WP4480,0.26438732487796024,2.4924582144313088,3.3158171385080513,"['NFKBIA', 'NFKB1']",0.9997592994748913,0,0,2
109,Unfolded protein response WP4925,0.2669296305603632,1.5581632653061224,2.057975625115505,"['XBP1', 'HSPA5', 'DDIT3', 'BBC3', 'ATF4']",0.9997592994748913,0,0,5
110,miRNA targets in ECM and membrane receptors WP2911,0.27267696627847915,1.661906704746362,2.1595936812550764,"['COL4A2', 'COL4A1', 'SDC2', 'LAMC1']",0.9997592994748913,0,0,4
111,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.27267696627847915,1.661906704746362,2.1595936812550764,"['NFKBIA', 'ITPR1', 'NFKBIE', 'NFKB1']",0.9997592994748913,0,0,4
112,Urea cycle and metabolism of amino groups WP497,0.27267696627847915,1.661906704746362,2.1595936812550764,"['ODC1', 'PYCR1', 'CKB', 'SRM']",0.9997592994748913,0,0,4
113,Leptin signaling pathway WP2034,0.27391831684819273,1.2470299057763212,1.614810613169492,"['NCOA1', 'GSK3A', 'ROCK2', 'STAT1', 'ACACB', 'NFKB1', 'CDC42', 'CCND1', 'CFL2', 'LEPR', 'BAX', 'RAC1', 'HRAS', 'MAPK3']",0.9997592994748913,0,0,14
114,Pathogenic Escherichia coli infection WP2272,0.2740522404765843,1.3124529114196535,1.6988869951940169,"['CDC42', 'TUBA1A', 'TUBB2A', 'YWHAQ', 'ROCK2', 'ARPC3', 'NCL', 'ARPC4', 'ARPC5', 'ACTG1']",0.9997592994748913,0,0,10
115,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.27474964851140454,1.8694942903752039,2.4151902608367877,"['BMP2', 'SMURF1', 'RUNX2']",0.9997592994748913,0,0,3
116,Cysteine and methionine catabolism WP4504,0.27474964851140454,1.8694942903752039,2.4151902608367877,"['AHCY', 'SUOX', 'CDO1']",0.9997592994748913,0,0,3
117,Glycolysis in senescence WP5049,0.27474964851140454,1.8694942903752039,2.4151902608367877,"['LDHA', 'PGK1', 'GAPDH']",0.9997592994748913,0,0,3
118,Homologous recombination WP186,0.27474964851140454,1.8694942903752039,2.4151902608367877,"['POLD4', 'MRE11', 'POLD2']",0.9997592994748913,0,0,3
119,"NAD metabolism, sirtuins and aging WP3630",0.27474964851140454,1.8694942903752039,2.4151902608367877,"['TFAM', 'PPARG', 'NFKB1']",0.9997592994748913,0,0,3
120,RAS and bradykinin pathways in COVID-19 WP4969,0.27474964851140454,1.8694942903752039,2.4151902608367877,"['KLKB1', 'PRKG1', 'NFKB1']",0.9997592994748913,0,0,3
121,Ebola Virus Pathway on Host WP4217,0.27583472168414747,1.199865935025254,1.5453714430951513,"['STAT1', 'VPS33A', 'VPS4A', 'HLA-B', 'CLTA', 'HLA-A', 'HLA-F', 'NFKB1', 'ASGR1', 'IGF1R', 'ACTG1', 'RHOB', 'CDC42', 'PIK3CA', 'CTSL', 'RAC1', 'CLEC4G', 'CTSB', 'MAPK3']",0.9997592994748913,0,0,19
122,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.2777129709622625,1.1802677344223027,1.5121202816709,"['RYR2', 'NTRK2', 'CHRNA4', 'YWHAB', 'MBD1', 'ATP1A3', 'YBX1', 'ASCL1', 'NFKB1', 'GCK', 'HSP90B1', 'SOX2', 'YWHAQ', 'PRKAR1A', 'SST', 'TPPP', 'PRKACA', 'SCN3B', 'ALDOA', 'GAPDH', 'SLC25A4', 'VAMP2']",0.9997592994748913,0,0,22
123,Regulation of toll-like receptor signaling pathway WP1449,0.27911384941767337,1.2114965428337043,1.5460337682039131,"['OTUD5', 'CUEDC2', 'STAT1', 'PELI3', 'NFKB1', 'NFKBIA', 'MAPK10', 'PIK3CA', 'TOLLIP', 'AKT3', 'TAB2', 'FADD', 'RAC1', 'SQSTM1', 'CTNNAL1', 'IFNAR1', 'MAPK3']",0.9997592994748913,0,0,17
124,Small cell lung cancer WP4658,0.27911384941767337,1.2114965428337043,1.5460337682039131,"['CDKN1B', 'GADD45A', 'LAMC1', 'NFKB1', 'CKS1B', 'RXRB', 'NFKBIA', 'CDK6', 'CCND1', 'PIK3CA', 'COL4A2', 'COL4A1', 'AKT3', 'CYCS', 'BAX', 'SKP1', 'NFKBIB']",0.9997592994748913,0,0,17
125,Complement system WP2806,0.2846963034101359,1.3200663748737433,1.6584419838974893,"['RPS19', 'APOA1', 'CD59', 'TXN', 'CALR', 'LAMC1', 'PRKACA', 'KLKB1', 'GNAI2']",0.9997592994748913,0,0,9
126,Aryl Hydrocarbon Receptor Netpath WP2586,0.2961630911772575,1.3297370930390955,1.6180839232546778,"['HSP90AA1', 'CDKN1B', 'CDC37', 'AIP', 'NF1', 'NCOA7', 'HRAS', 'NFKB1']",0.9997592994748913,0,0,8
127,Estrogen signaling pathway WP712,0.30180211549431446,1.4663865546218486,1.756707224184415,"['PIK3CA', 'GNB1', 'BRAF', 'PRKACA', 'NFKB1']",0.9997592994748913,0,0,5
128,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.30180211549431446,1.4663865546218486,1.756707224184415,"['TTC9', 'PNCK', 'CCND1', 'ERBB4', 'TPM3']",0.9997592994748913,0,0,5
129,SARS-CoV-2 mitochondrial interactions WP5038,0.30180211549431446,1.4663865546218486,1.756707224184415,"['TOMM70', 'NDUFB9', 'CTSL', 'PHB', 'NFKB1']",0.9997592994748913,0,0,5
130,Aflatoxin B1 metabolism WP699,0.3063776757139538,4.984107579462103,5.8958837909924995,['AKR7A2'],0.9997592994748913,0,0,1
131,Integrin-mediated Cell Adhesion WP185,0.30700032196927185,1.1910925079400048,1.4065688640451022,"['VAV3', 'ROCK2', 'PXN', 'ILK', 'BRAF', 'ITGAE', 'CDC42', 'MAPK10', 'RAP1A', 'ITGA10', 'AKT3', 'RAC3', 'RAC1', 'MAPK6', 'HRAS', 'VCL']",0.9997592994748913,0,0,16
132,3q29 copy number variation syndrome WP4906,0.3072632375690438,1.2467266775777415,1.4712003737002688,"['DYNC2H1', 'DLG1', 'DYNLT1', 'NCBP2', 'CEP350', 'PXN', 'MAD2L1BP', 'FBXO45', 'DYNLL1', 'DYNLL2', 'PIGX']",0.9997592994748913,0,0,11
133,Apoptosis Modulation by HSP70 WP384,0.3132454383917142,1.5339421900009416,1.780551387667864,"['MAPK10', 'CYCS', 'FADD', 'NFKB1']",0.9997592994748913,0,0,4
134,Ebstein-Barr virus LMP1 signaling WP262,0.3132454383917142,1.5339421900009416,1.780551387667864,"['NFKBIA', 'HSP90AA1', 'TRADD', 'NFKB1']",0.9997592994748913,0,0,4
135,Proteoglycan biosynthesis WP4784,0.3132454383917142,1.5339421900009416,1.780551387667864,"['CSGALNACT1', 'CANT1', 'B3GAT3', 'B4GALT7']",0.9997592994748913,0,0,4
136,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.31983393001037624,1.1337448559670782,1.292416288119062,"['RAB3A', 'YBX1', 'ACACB', 'CDC42', 'GRIP1', 'RAP1A', 'CDH2', 'DPYSL2', 'RACK1', 'KCNN2', 'RAC1', 'HRAS', 'MAPK3', 'VAV3', 'NTRK2', 'CDKL5', 'STAT1', 'EIF2S2', 'EEF2', 'NFKB1', 'NFKBIA', 'MAPK10', 'DLG1', 'BMP2', 'SQSTM1']",0.9997592994748913,0,0,25
137,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.32222078438474566,1.3597386688444264,1.5399289292301301,"['NFKBIA', 'NDUFA13', 'HSP90AA1', 'COPS6', 'RAC1', 'AAMP']",0.9997592994748913,0,0,6
138,The influence of laminopathies on Wnt signaling WP4844,0.32222078438474566,1.3597386688444264,1.5399289292301301,"['WNT10B', 'CDK6', 'CCND1', 'PPARG', 'EMD', 'RUNX2']",0.9997592994748913,0,0,6
139,Common Pathways Underlying Drug Addiction WP2636,0.32270663639909486,1.286736886510144,1.4553143639730444,"['GRM5', 'RAP1A', 'ADCY8', 'PRKACA', 'CALM1', 'ACTG1', 'MAPK3', 'GRIA4']",0.9997592994748913,0,0,8
140,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.32418923165523755,1.2005490338823672,1.3523319095083217,"['DCC', 'GADD45A', 'BRAF', 'BBC3', 'MAPK10', 'CCND1', 'AKT3', 'RAC3', 'CYCS', 'BAX', 'RAC1', 'EXOC2', 'MAPK3']",0.9997592994748913,0,0,13
141,Biomarkers for pyrimidine metabolism disorders WP4584,0.32428776356679617,1.661636759108211,1.8712090307446205,"['RRM2B', 'TK2', 'CKB']",0.9997592994748913,0,0,3
142,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.32428776356679617,1.661636759108211,1.8712090307446205,"['SFRP1', 'BMP2', 'SST']",0.9997592994748913,0,0,3
143,Cell Differentiation - Index expanded WP2023,0.32428776356679617,1.661636759108211,1.8712090307446205,"['SOX2', 'MEF2D', 'RUNX2']",0.9997592994748913,0,0,3
144,Galanin receptor pathway WP4970,0.32428776356679617,1.661636759108211,1.8712090307446205,"['CDKN1B', 'PPARG', 'VAMP2']",0.9997592994748913,0,0,3
145,Hedgehog Signaling Pathway Netpath WP47,0.32428776356679617,1.661636759108211,1.8712090307446205,"['STK36', 'SAP18', 'GLI3']",0.9997592994748913,0,0,3
146,IL1 and megakaryocytes in obesity WP2865,0.32428776356679617,1.661636759108211,1.8712090307446205,"['PIK3CA', 'TIMP2', 'NFKB1']",0.9997592994748913,0,0,3
147,NO metabolism in cystic fibrosis WP4947,0.32428776356679617,1.661636759108211,1.8712090307446205,"['PRMT5', 'PRMT2', 'PRMT1']",0.9997592994748913,0,0,3
148,Overview of nanoparticle effects WP3287,0.32428776356679617,1.661636759108211,1.8712090307446205,"['COL4A1', 'AKT3', 'BAX']",0.9997592994748913,0,0,3
149,Supression of HMGB1 mediated inflammation by THBD WP4479,0.3315763738232494,1.9938035059111292,2.2009539226690147,"['NFKBIA', 'NFKB1']",0.9997592994748913,0,0,2
150,Copper homeostasis WP3286,0.33419857385064994,1.2465249386753885,1.36621617625822,"['BACE1', 'CCS', 'CCND1', 'PIK3CA', 'SCO2', 'COX17', 'COX11', 'ATOX1', 'SOD1']",0.9997592994748913,0,0,9
151,RANKL/RANK signaling pathway WP2018,0.33419857385064994,1.2465249386753885,1.36621617625822,"['CDC42', 'NFKBIA', 'STAT1', 'MITF', 'TAB2', 'RAC1', 'SQSTM1', 'NFKB1', 'MAPK3']",0.9997592994748913,0,0,9
152,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.33419857385064994,1.2465249386753885,1.36621617625822,"['EIF4A2', 'MAPK10', 'PIK3CA', 'AKT3', 'PRKACA', 'EIF4G3', 'EIF4B', 'MAPK3', 'EIF4G1']",0.9997592994748913,0,0,9
153,DNA Mismatch Repair WP531,0.3373034353287722,1.3848072562358276,1.5049702391740265,"['POLE4', 'POLD4', 'PCNA', 'POLD2', 'POLE3']",0.9997592994748913,0,0,5
154,DNA Replication WP466,0.33756656839547317,1.2925895666908738,1.4037426376026505,"['POLD4', 'PCNA', 'UBC', 'POLD2', 'MCM4', 'MCM6', 'UBA52']",0.9997592994748913,0,0,7
155,Signaling of Hepatocyte Growth Factor Receptor WP313,0.33756656839547317,1.2925895666908738,1.4037426376026505,"['RAP1A', 'PIK3CA', 'RASA1', 'PXN', 'GAB1', 'HRAS', 'MAPK3']",0.9997592994748913,0,0,7
156,Regulation of Actin Cytoskeleton WP51,0.3413897018945395,1.1246694401444788,1.208716699790227,"['CYFIP2', 'CHRM1', 'ROCK2', 'PXN', 'BRK1', 'BRAF', 'ARPC5', 'SSH2', 'ACTG1', 'CDC42', 'DIAPH3', 'MRAS', 'PIK3CA', 'CFL2', 'TMSB4X', 'RAC3', 'RAC1', 'MAPK6', 'FGF12', 'VCL', 'FGFR2', 'ARHGEF6', 'MAPK3']",0.9997592994748913,0,0,23
157,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.3509057385814576,1.1635122217670353,1.2184737962974592,"['THRA', 'ADCY8', 'CREB3', 'RPS6KA6', 'TBC1D4', 'PIK3CA', 'AKT3', 'ZNF516', 'PPARG', 'PRKACA', 'PLCB1', 'MAP4K5', 'HRAS', 'MGLL']",0.9997592994748913,0,0,14
158,Prion disease pathway WP3995,0.3541747600594526,1.3005130754345162,1.3498868139828268,"['PDIA3', 'HSPA5', 'RFX5', 'NFKB1', 'HSP90B1', 'MAPK3']",0.9997592994748913,0,0,6
159,Tumor suppressor activity of SMARCB1 WP4204,0.3541747600594526,1.3005130754345162,1.3498868139828268,"['CDK6', 'H3F3B', 'H3F3A', 'DPF2', 'ARID1B', 'GLI3']",0.9997592994748913,0,0,6
160,Hippo-Yap signaling pathway WP4537,0.3542767224454546,1.4242583202191526,1.4779200573603195,"['YWHAQ', 'TNIK', 'TEAD1', 'MAP4K3']",0.9997592994748913,0,0,4
161,Modulators of TCR signaling and T cell activation WP5072,0.3594969199835443,1.21273563015182,1.2406887854458601,"['NFKBIA', 'FIBP', 'CDKN1B', 'NDUFB10', 'CBLB', 'ELOB', 'RNF7', 'MEF2D', 'NFKB1']",0.9997592994748913,0,0,9
162,Nuclear Receptors Meta-Pathway WP2882,0.36615087006460223,1.0792762855581193,1.0843594795995255,"['CDKN1B', 'HSP90AB1', 'MGST3', 'GSTP1', 'KEAP1', 'TXN', 'SLC6A1', 'SLC5A3', 'FGD4', 'RGS2', 'CCND1', 'PRDX1', 'ME1', 'SLC39A7', 'SLC39A1', 'NCOA1', 'GSTM3', 'NCOA2', 'ABCG8', 'HSP90AA1', 'PLK2', 'NCOA3', 'SLC2A13', 'PTGES3', 'AIP', 'APOA1', 'SMARCA1', 'CES4A', 'TGFBR3', 'PSMC5', 'NAV3', 'ACOX1', 'CDC37', 'BAX', 'SQSTM1', 'CES2', 'SLC27A5']",0.9997592994748913,0,0,37
163,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.3730985874369048,1.3118152524167561,1.2933351662635082,"['CCND2', 'CCND1', 'NFKB1', 'RUNX2', 'FGFR2']",0.9997592994748913,0,0,5
164,Airway smooth muscle cell contraction WP4962,0.37380090032784524,1.4953507340946166,1.4714729367598396,"['ROCK2', 'PLCB1', 'CALM1']",0.9997592994748913,0,0,3
165,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.37380090032784524,1.4953507340946166,1.4714729367598396,"['CDK8', 'CCND1', 'SOX4']",0.9997592994748913,0,0,3
166,miRNAs involved in DNA damage response WP1545,0.37380090032784524,1.4953507340946166,1.4714729367598396,"['CDKN1B', 'CDK6', 'CCND1']",0.9997592994748913,0,0,3
167,EGF/EGFR signaling pathway WP437,0.38283960793627525,1.0858399319764043,1.0425574355651308,"['NDUFA13', 'PCNA', 'STXBP1', 'PEBP1', 'CBLB', 'NEDD8', 'ASAP1', 'CDC42', 'RAP1A', 'STMN1', 'AP2S1', 'RICTOR', 'RAC1', 'HRAS', 'MEF2D', 'SH3GL2', 'AP2M1', 'VAV3', 'RALBP1', 'STAT1', 'NCOA3', 'GAB1', 'BRAF', 'PTPN12', 'AP2B1', 'EPN1', 'RASA1']",0.9997592994748913,0,0,27
168,CAMKK2  Pathway WP4874,0.3863348344110651,1.2462229481420988,1.1852213802507563,"['FIS1', 'MAP1LC3A', 'RAC1', 'CALM1', 'SQSTM1', 'MAPK3']",0.9997592994748913,0,0,6
169,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.3863348344110651,1.2462229481420988,1.1852213802507563,"['STAR', 'PIK3CA', 'PLCB1', 'HRAS', 'NFKB1', 'MAPK3']",0.9997592994748913,0,0,6
170,Immune response to tuberculosis WP4197,0.3952873085188792,1.3291989664082686,1.2336859388872068,"['STAT1', 'TAP1', 'IFIT3', 'IFNAR1']",0.9997592994748913,0,0,4
171,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.3952873085188792,1.3291989664082686,1.2336859388872068,"['B3GALNT1', 'SGPL1', 'GALNT1', 'SGPP2']",0.9997592994748913,0,0,4
172,Folate Metabolism WP176,0.3963087159371283,1.2032482533243183,1.1136806020437298,"['AHCY', 'GPX4', 'FLAD1', 'MTHFD2', 'APOA1', 'NFKB1', 'SOD1']",0.9997592994748913,0,0,7
173,G13 Signaling Pathway WP524,0.3963087159371283,1.2032482533243183,1.1136806020437298,"['CDC42', 'MAPK10', 'PIK3CA', 'ROCK2', 'CFL2', 'RAC1', 'CALM1']",0.9997592994748913,0,0,7
174,Bile acids synthesis and enterohepatic circulation  WP4389,0.3968652434066104,1.661367033564343,1.535366454357351,"['ABCG8', 'MAPK3']",0.9997592994748913,0,0,2
175,"Degradation pathway of sphingolipids, including diseases WP4153",0.3968652434066104,1.661367033564343,1.535366454357351,"['NEU3', 'NEU1']",0.9997592994748913,0,0,2
176,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.3968652434066104,1.661367033564343,1.535366454357351,"['ELOB', 'ELOC']",0.9997592994748913,0,0,2
177,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.3968652434066104,1.661367033564343,1.535366454357351,"['SQSTM1', 'NFKB1']",0.9997592994748913,0,0,2
178,Gastrin signaling pathway WP4659,0.40554776107602597,1.0944083589379185,0.9877217430672194,"['CDKN1B', 'PXN', 'NFKB1', 'RHOB', 'NFKBIA', 'CDC42', 'TJP1', 'BMP2', 'CCND1', 'KAT5', 'PIK3CA', 'PPARG', 'PRKD1', 'RAC1', 'PRKACA', 'HRAS', 'MEF2D', 'MAPK3']",0.9997592994748913,0,0,18
179,Gastric Cancer Network 2 WP2363,0.4088756752736894,1.246122448979592,1.1144623119415638,"['OTUD5', 'AHCTF1', 'DSCC1', 'UBE2T', 'CEBPZ']",0.9997592994748913,0,0,5
180,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.4088756752736894,1.246122448979592,1.1144623119415638,"['RAB3B', 'FGD4', 'RAB3A', 'MFN2', 'SBF2']",0.9997592994748913,0,0,5
181,Oxidative Stress WP408,0.4088756752736894,1.246122448979592,1.1144623119415638,"['MAPK10', 'TXNRD2', 'NFKB1', 'TXN2', 'SOD1']",0.9997592994748913,0,0,5
182,Sphingolipid pathway WP1422,0.4088756752736894,1.246122448979592,1.1144623119415638,"['ASAH1', 'SGPL1', 'SERINC1', 'SGPP2', 'PLPP1']",0.9997592994748913,0,0,5
183,miRNA regulation of prostate cancer signaling pathways WP3981,0.41847867223105206,1.1962760310330747,1.0421111646386585,"['NFKBIA', 'CDKN1B', 'CCND1', 'PIK3CA', 'AKT3', 'NFKB1']",0.9997592994748913,0,0,6
184,Neural Crest Cell Migration in Cancer WP4565,0.41847867223105206,1.1962760310330747,1.0421111646386585,"['NTRK2', 'ARF1', 'TRIO', 'PIK3CA', 'AKT3', 'RAC1']",0.9997592994748913,0,0,6
185,NRF2 pathway WP2884,0.4205773664972101,1.0865253149912706,0.9410687263306619,"['GSTM3', 'HSP90AA1', 'HSP90AB1', 'MGST3', 'SLC2A13', 'GSTP1', 'KEAP1', 'TXN', 'SLC6A1', 'SLC5A3', 'CES4A', 'PRDX1', 'ME1', 'SLC39A7', 'SLC39A1', 'SQSTM1', 'CES2']",0.9997592994748913,0,0,17
186,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.4223354847201829,2.4918500407497963,2.147863332715954,['VIP'],0.9997592994748913,0,0,1
187,GABA metabolism (aka GHB) WP4157,0.4223354847201829,2.4918500407497963,2.147863332715954,['AKR7A2'],0.9997592994748913,0,0,1
188,let-7 inhibition of ES cell reprogramming WP3299,0.4223354847201829,2.4918500407497963,2.147863332715954,['SOX2'],0.9997592994748913,0,0,1
189,Secretion of Hydrochloric Acid in Parietal Cells WP2597,0.4223354847201829,2.4918500407497963,2.147863332715954,['CHRM1'],0.9997592994748913,0,0,1
190,Steroid Biosynthesis WP496,0.4223354847201829,2.4918500407497963,2.147863332715954,['HSD17B1'],0.9997592994748913,0,0,1
191,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.4225385828831618,1.3592985318107667,1.1710010446835974,"['CD63', 'CD81', 'SOD1']",0.9997592994748913,0,0,3
192,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.4225385828831618,1.3592985318107667,1.1710010446835974,"['CDH2', 'RUNX2', 'MAPK3']",0.9997592994748913,0,0,3
193,Transcription co-factors SKI and SKIL protein partners WP4533,0.4225385828831618,1.3592985318107667,1.1710010446835974,"['PRMT5', 'NF1', 'TEAD1']",0.9997592994748913,0,0,3
194,Alzheimer's disease WP2059,0.42807701997746456,1.0983564458140729,0.9319028839320357,"['ATP5MD', 'PSEN2', 'ITPR1', 'HSD17B10', 'BACE1', 'PPP3CA', 'CYCS', 'CALM3', 'FADD', 'PLCB1', 'CALM1', 'GAPDH', 'MAPK3']",0.9997592994748913,0,0,13
195,Canonical and non-canonical Notch signaling WP3845,0.43584967336132724,1.2460220318237454,1.03476881617026,"['MFAP1', 'PSEN2', 'DLL3', 'DLK2']",0.9997592994748913,0,0,4
196,miRNA regulation of p53 pathway in prostate cancer WP3982,0.43584967336132724,1.2460220318237454,1.03476881617026,"['EI24', 'SHISA5', 'BAX', 'BBC3']",0.9997592994748913,0,0,4
197,Endothelin Pathways WP2197,0.4443504201856537,1.1866861030126337,0.9625706935387836,"['NPY1R', 'RIIAD1', 'GNB5', 'PLCB1', 'CALM1']",0.9997592994748913,0,0,5
198,Development of ureteric collection system WP5053,0.4503998980697296,1.1501711844708986,0.9173988827971541,"['GRIP1', 'CCND1', 'ILK', 'SLIT2', 'GLI3', 'FGFR2']",0.9997592994748913,0,0,6
199,Spinal Cord Injury WP2431,0.4513704881936392,1.0735701005262661,0.8539893672113371,"['CDKN1B', 'GADD45A', 'ROCK2', 'MIF', 'RHOB', 'CDC42', 'PPP3CA', 'CCND1', 'COL4A1', 'APEX1', 'RAC1', 'LTB', 'SLIT2', 'MAPK3']",0.9997592994748913,0,0,14
200,IL-6 signaling pathway WP364,0.45500156660315105,1.1254348513598988,0.8862286446964942,"['NCOA1', 'STAT1', 'GAB1', 'RAC1', 'VIP', 'MAPK3', 'NR2F6']",0.9997592994748913,0,0,7
201,EDA signaling in hair follicle development WP3930,0.45901207715307385,1.4239124104594956,1.108770346405109,"['BMP1', 'LTB']",0.9997592994748913,0,0,2
202,Osteoclast Signaling WP12,0.45901207715307385,1.4239124104594956,1.108770346405109,"['ATP6V1G1', 'IFNAR1']",0.9997592994748913,0,0,2
203,Thiamine metabolic pathways WP4297,0.45901207715307385,1.4239124104594956,1.108770346405109,"['BCKDK', 'TKT']",0.9997592994748913,0,0,2
204,Trans-sulfuration pathway WP2333,0.45901207715307385,1.4239124104594956,1.108770346405109,"['AHCY', 'MAT2B']",0.9997592994748913,0,0,2
205,Cardiac Hypertrophic Response WP2795,0.4616752448782221,1.0940609855812378,0.8455926990156185,"['PPP3CA', 'CAMK2D', 'RAC1', 'PRKD1', 'CALM1', 'PRKG1', 'NFKB1', 'FGFR2', 'MAPK3']",0.9997592994748913,0,0,9
206,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.4616752448782221,1.0940609855812378,0.8455926990156185,"['RXRB', 'IFI27L2', 'CAMK2D', 'STAT1', 'ISG15', 'PLCB1', 'HRAS', 'NFKB1', 'MAPK3']",0.9997592994748913,0,0,9
207,p53 transcriptional gene network WP4963,0.4616752448782221,1.0940609855812378,0.8455926990156185,"['RRM2B', 'SIVA1', 'GADD45A', 'SESN1', 'SESN2', 'BAX', 'FANCC', 'ISG15', 'BBC3']",0.9997592994748913,0,0,9
208,MET in type 1 papillary renal cell carcinoma WP4205,0.46421363491112916,1.083488930381435,0.8314806871652789,"['CDC42', 'RAP1A', 'PIK3CA', 'AKT3', 'RPL11', 'GAB1', 'BRAF', 'RAC1', 'HRAS', 'MAPK3']",0.9997592994748913,0,0,10
209,Overview of interferons-mediated signaling pathway WP4558,0.4698972511833148,1.245921696574225,0.9409714254858178,"['PIK3CA', 'STAT1', 'IFNAR1']",0.9997592994748913,0,0,3
210,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.4698972511833148,1.245921696574225,0.9409714254858178,"['CCND1', 'NFKB1', 'BCL2L2']",0.9997592994748913,0,0,3
211,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.47559554864272985,1.1726306189550484,0.871484387243783,"['TGFBR3', 'RUNX2', 'MAPK3', 'FBN1']",0.9997592994748913,0,0,4
212,IL-7 signaling pathway WP205,0.47559554864272985,1.1726306189550484,0.871484387243783,"['CDKN1B', 'CCND1', 'STAT1', 'MAPK3']",0.9997592994748913,0,0,4
213,Microglia Pathogen Phagocytosis Pathway WP3937,0.47559554864272985,1.1726306189550484,0.871484387243783,"['VAV3', 'PIK3CA', 'RAC3', 'RAC1']",0.9997592994748913,0,0,4
214,PKC-gamma calcium signaling pathway in ataxia WP4760,0.47559554864272985,1.1726306189550484,0.871484387243783,"['ITPR1', 'CA8', 'PLCB1', 'GRIA4']",0.9997592994748913,0,0,4
215,Type II interferon signaling (IFNG) WP619,0.47559554864272985,1.1726306189550484,0.871484387243783,"['STAT1', 'HLA-B', 'TAP1', 'ISG15']",0.9997592994748913,0,0,4
216,Hepatitis B infection WP4666,0.4781032026391159,1.0383299110198494,0.7662134047487243,"['PCNA', 'ATP6AP1', 'YWHAB', 'STAT1', 'BRAF', 'NFKB1', 'DDB1', 'MAPK10', 'CREB3', 'YWHAQ', 'PIK3CA', 'AKT3', 'CYCS', 'BAX', 'TAB2', 'FADD', 'HRAS', 'IFNAR1', 'ATF4', 'MAPK3']",0.9997592994748913,0,0,20
217,IL17 signaling pathway WP2112,0.4792690809022388,1.1326530612244898,0.8330584928299374,"['PIK3CA', 'IL17RE', 'NFKB1', 'MAPK3', 'NFKBIB']",0.9997592994748913,0,0,5
218,Intraflagellar transport proteins binding to dynein WP4532,0.4792690809022388,1.1326530612244898,0.8330584928299374,"['DYNC2H1', 'DYNLT1', 'WDR19', 'DYNLL1', 'DYNLL2']",0.9997592994748913,0,0,5
219,Parkinson's disease pathway WP2371,0.4819102541989391,1.107481511728143,0.8084585985001171,"['UCHL1', 'PINK1', 'UBB', 'SYT11', 'CYCS', 'UBE2L6']",0.9997592994748913,0,0,6
220,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.4819102541989391,1.107481511728143,0.8084585985001171,"['NFKBIA', 'FADD', 'RAC1', 'NFKB1', 'MAPK3', 'NFKBIB']",0.9997592994748913,0,0,6
221,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.4855751797727355,1.0775466925855157,0.7784425241093764,"['NFKBIA', 'MAPK10', 'TOLLIP', 'TAB2', 'IL1RAP', 'NFKB1', 'MAPK3', 'NFKBIB']",0.9997592994748913,0,0,8
222,IL-1 signaling pathway WP195,0.4869338651304934,1.0679243079079548,0.768507129270033,"['NFKBIA', 'TOLLIP', 'HSPB2', 'TAB2', 'IL1RAP', 'SQSTM1', 'NFKB1', 'MAPK3', 'NFKBIB']",0.9997592994748913,0,0,9
223,Acute viral myocarditis WP4298,0.4880918037276154,1.060348953574381,0.7605371621032062,"['CCND1', 'STAT1', 'RASA1', 'ILK', 'RAC3', 'CYCS', 'BAX', 'EIF4G2', 'MAPK3', 'EIF4G1']",0.9997592994748913,0,0,10
224,Pathways Regulating Hippo Signaling WP4540,0.5113438870753677,1.0259536833987999,0.6881204177434155,"['NTRK2', 'PRKAG1', 'IGF1R', 'GNAI2', 'CDC42', 'GNAL', 'CDH2', 'PRKAR1A', 'RAC1', 'PRKACA', 'PLCB1', 'TEAD1', 'FGFR2', 'CDH18']",0.9997592994748913,0,0,14
225,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.5117083200529469,1.038173142467621,0.6955765283528155,"['NFKBIA', 'PIK3CA', 'RASA1', 'STMN1', 'PXN', 'BAX', 'RAC1', 'HRAS', 'NFKB1', 'MAPK3']",0.9997592994748913,0,0,10
226,Neural Crest Cell Migration during Development WP4564,0.5134099983141469,1.083318544809228,0.7222273881430937,"['ARF1', 'TRIO', 'PIK3CA', 'AKT3', 'RAC1']",0.9997592994748913,0,0,5
227,1q21.1 copy number variation syndrome WP4905,0.5142162920881326,1.1073938075162066,0.736540135273791,"['TJP1', 'PYGO2', 'AFDN', 'PRKAG1']",0.9997592994748913,0,0,4
228,Physiological and pathological hypertrophy of the heart WP1528,0.5142162920881326,1.1073938075162066,0.736540135273791,"['PPP3CA', 'CAMK2D', 'RAC1', 'CALM1']",0.9997592994748913,0,0,4
229,Sphingolipid Metabolism (general overview) WP4725,0.5142162920881326,1.1073938075162066,0.736540135273791,"['ASAH1', 'SGPL1', 'DEGS1', 'SGPP2']",0.9997592994748913,0,0,4
230,BMP Signaling Pathway in Eyelid Development WP3927,0.5154096007880444,1.1499874513740744,0.7622040389176628,"['SFRP1', 'FGFR2', 'MAPK3']",0.9997592994748913,0,0,3
231,Dopamine metabolism WP2436,0.5172429754076993,1.24582144313086,0.8212984964191049,"['PRKACA', 'SOD1']",0.9997592994748913,0,0,2
232,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.5172429754076993,1.24582144313086,0.8212984964191049,"['GABBR1', 'GRM5']",0.9997592994748913,0,0,2
233,miR-509-3p alteration of YAP1/ECM axis WP3967,0.5172429754076993,1.24582144313086,0.8212984964191049,"['SPARC', 'TEAD1']",0.9997592994748913,0,0,2
234,Nanoparticle triggered regulated necrosis WP2513,0.5172429754076993,1.24582144313086,0.8212984964191049,"['TRADD', 'FADD']",0.9997592994748913,0,0,2
235,Osteopontin Signaling WP1434,0.5172429754076993,1.24582144313086,0.8212984964191049,"['NFKB1', 'MAPK3']",0.9997592994748913,0,0,2
236,TCA cycle in senescence WP5050,0.5172429754076993,1.24582144313086,0.8212984964191049,"['ME1', 'BRAF']",0.9997592994748913,0,0,2
237,Transcriptional cascade regulating adipogenesis WP4211,0.5172429754076993,1.24582144313086,0.8212984964191049,"['DDIT3', 'PPARG']",0.9997592994748913,0,0,2
238,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.5189143414273923,1.661097527845694,1.0897073113891005,['NFKB1'],0.9997592994748913,0,0,1
239,Composition of Lipid Particles WP3601,0.5189143414273923,1.661097527845694,1.0897073113891005,['APOA1'],0.9997592994748913,0,0,1
240,Gene regulatory network modelling somitogenesis  WP2854,0.5189143414273923,1.661097527845694,1.0897073113891005,['RIPPLY2'],0.9997592994748913,0,0,1
241,Macrophage markers WP4146,0.5189143414273923,1.661097527845694,1.0897073113891005,['CD83'],0.9997592994748913,0,0,1
242,Sulindac Metabolic Pathway WP2542,0.5189143414273923,1.661097527845694,1.0897073113891005,['MSRB2'],0.9997592994748913,0,0,1
243,DNA damage response (only ATM dependent) WP710,0.5302833084644855,1.010024368630926,0.6407027677827372,"['WNT10B', 'CDKN1B', 'NFKB1', 'BBC3', 'CDC42', 'MAPK10', 'CCND2', 'CCND1', 'PIK3CA', 'CCNG2', 'AKT3', 'RAC3', 'BAX', 'RAC1', 'HRAS']",0.9997592994748913,0,0,15
244,Glioblastoma signaling pathways WP2261,0.5317907351171818,1.0121314496314497,0.6391662958612853,"['CDKN1B', 'GAB1', 'BRAF', 'IGF1R', 'CCND2', 'CDK6', 'CCND1', 'PIK3CA', 'AKT3', 'NF1', 'HRAS', 'FGFR2', 'MAPK3']",0.9997592994748913,0,0,13
245,Non-small cell lung cancer WP4255,0.5327054889162854,1.0134524792385022,0.638258751796958,"['RXRB', 'CDK6', 'CCND1', 'PIK3CA', 'GADD45A', 'AKT3', 'CRABP1', 'CYCS', 'BAX', 'BRAF', 'HRAS', 'MAPK3']",0.9997592994748913,0,0,12
246,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.5430438397821266,1.03093451232734,0.6294527635723907,"['MAP1LC3A', 'EIF2B2', 'ILK', 'RICTOR', 'NFKB1', 'IGF1R']",0.9997592994748913,0,0,6
247,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.5465839880442154,1.0380952380952382,0.6270793872584827,"['NFKBIA', 'PPP3CA', 'SUPT4H1', 'SUPT5H', 'NFKB1']",0.9997592994748913,0,0,5
248,Nuclear receptors WP170,0.5465839880442154,1.0380952380952382,0.6270793872584827,"['RXRB', 'THRA', 'ROR1', 'PPARG', 'NR2F6']",0.9997592994748913,0,0,5
249,PDGFR-beta pathway WP3972,0.5465839880442154,1.0380952380952382,0.6270793872584827,"['PIK3CA', 'STAT1', 'RASA1', 'HRAS', 'MAPK3']",0.9997592994748913,0,0,5
250,Cannabinoid receptor signaling WP3869,0.55146108255715,1.0490240288604007,0.6243623273610622,"['MAPK10', 'PRKAR1A', 'PRKACA', 'MAPK3']",0.9997592994748913,0,0,4
251,Sphingolipid Metabolism (integrated pathway) WP4726,0.55146108255715,1.0490240288604007,0.6243623273610622,"['ASAH1', 'SGPL1', 'DEGS1', 'SGPP2']",0.9997592994748913,0,0,4
252,Constitutive Androstane Receptor Pathway WP2875,0.5587304662247911,1.067758098345374,0.6215292757232488,"['NCOA1', 'NCOA2', 'HSP90AA1']",0.9997592994748913,0,0,3
253,"GPCRs, Class B Secretin-like WP334",0.5587304662247911,1.067758098345374,0.6215292757232488,"['ADGRE5', 'ADGRL2', 'ADGRL3']",0.9997592994748913,0,0,3
254,Nanomaterial induced apoptosis WP2507,0.5587304662247911,1.067758098345374,0.6215292757232488,"['BAX', 'CYCS', 'FADD']",0.9997592994748913,0,0,3
255,Nicotine Activity on Dopaminergic Neurons WP1602,0.5587304662247911,1.067758098345374,0.6215292757232488,"['CHRNA4', 'GNB1', 'PRKACA']",0.9997592994748913,0,0,3
256,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.5587304662247911,1.067758098345374,0.6215292757232488,"['GSK3A', 'BAX', 'BCL2L2']",0.9997592994748913,0,0,3
257,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.5637089805034368,0.9964854924397221,0.5712025766522166,"['VAV3', 'BEX3', 'CDKN1B', 'HSPA5', 'SERBP1', 'RNF7', 'SQSTM1', 'NFKB1']",0.9997592994748913,0,0,8
258,Circadian rhythm related genes WP3594,0.5695186828885047,0.9806065908428113,0.5520459056611636,"['AHCY', 'CHRM1', 'ROCK2', 'BHLHE41', 'HEBP1', 'DBP', 'UBC', 'RPS27A', 'SKP1', 'PRMT5', 'NCOA2', 'KCND2', 'USP2', 'DYRK1A', 'NR2F6', 'MAPK10', 'STAR', 'PSPC1', 'CRY2', 'CRH', 'CRY1', 'PPARG', 'ATF5', 'UBA52', 'ATF4']",0.9997592994748913,0,0,25
259,Cancer immunotherapy by PD-1 blockade WP4585,0.571130345588762,1.1073062463196992,0.620244106210223,"['HLA-A', 'NFKB1']",0.9997592994748913,0,0,2
260,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.571130345588762,1.1073062463196992,0.620244106210223,"['NFKBIA', 'NFKB1']",0.9997592994748913,0,0,2
261,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.571130345588762,1.1073062463196992,0.620244106210223,"['NFKB1', 'SOX4']",0.9997592994748913,0,0,2
262,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.571130345588762,1.1073062463196992,0.620244106210223,"['STAG1', 'ANAPC11']",0.9997592994748913,0,0,2
263,Serotonin and anxiety-related events WP3944,0.571130345588762,1.1073062463196992,0.620244106210223,"['PPP3CA', 'CRH']",0.9997592994748913,0,0,2
264,Glycogen Synthesis and Degradation WP500,0.572390847405302,0.9964883625969784,0.5559739621173884,"['GSK3A', 'PPP2R2B', 'PPP2R5B', 'PHKA1', 'CALM3', 'CALM1']",0.9997592994748913,0,0,6
265,Hedgehog Signaling Pathway WP4249,0.572390847405302,0.9964883625969784,0.5559739621173884,"['CCND2', 'CCND1', 'SMURF1', 'FBXL17', 'PRKACA', 'GLI3']",0.9997592994748913,0,0,6
266,Hepatitis C and Hepatocellular Carcinoma WP3646,0.572390847405302,0.9964883625969784,0.5559739621173884,"['UCHL1', 'CCND1', 'COL4A2', 'RAC1', 'NFKB1', 'MAPK3']",0.9997592994748913,0,0,6
267,Endometrial cancer WP4155,0.580290551660317,0.9768635470548137,0.5316348824050988,"['CCND1', 'PIK3CA', 'GADD45A', 'AKT3', 'ILK', 'BAX', 'BRAF', 'HRAS', 'FGFR2', 'MAPK3']",0.9997592994748913,0,0,10
268,AGE/RAGE pathway WP2324,0.5840886371071757,0.9747413701162502,0.524120902563902,"['CDC42', 'NFKBIA', 'STAT1', 'CYCS', 'RAC1', 'DDOST', 'NFKB1', 'MAPK3', 'SOD1']",0.9997592994748913,0,0,9
269,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.5871335582690773,0.9964912280701754,0.5306345267383292,"['BMP2', 'THRA', 'STAT1', 'MAPK3']",0.9997592994748913,0,0,4
270,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.591160720404761,0.9665737650812277,0.5080962716101082,"['GAB1', 'BRAF', 'IGF1R', 'MRAS', 'CCND1', 'PIK3CA', 'AKT3', 'PDGFC', 'NF1', 'BAX', 'HRAS', 'FGFR2', 'MAPK3']",0.9997592994748913,0,0,13
271,Pathways in clear cell renal cell carcinoma WP4018,0.5943729932997484,0.9641767789470904,0.5016112547866661,"['LDHA', 'BHLHE41', 'ME1', 'PGK1', 'PLOD2', 'ENO2', 'ALDOA', 'GAPDH', 'SQSTM1', 'ACACB', 'PFKM', 'KCNJ2']",0.9997592994748913,0,0,12
272,Prolactin Signaling Pathway WP2037,0.5980165185344347,0.9613590030723289,0.4942701399779225,"['NFKBIA', 'PIK3CA', 'STAT1', 'PXN', 'RAC1', 'PPIB', 'CTSD', 'HRAS', 'NFKB1', 'MAPK3', 'NFKBIB']",0.9997592994748913,0,0,11
273,ACE Inhibitor Pathway WP554,0.5993517650455329,1.245721271393643,0.6376929398399445,['ATP6AP2'],0.9997592994748913,0,0,1
274,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.5993517650455329,1.245721271393643,0.6376929398399445,['PPARG'],0.9997592994748913,0,0,1
275,FTO Obesity Variant Mechanism WP3407,0.5993517650455329,1.245721271393643,0.6376929398399445,['ARID5B'],0.9997592994748913,0,0,1
276,Mitochondrial fatty acid synthesis pathway WP4317,0.5993517650455329,1.245721271393643,0.6376929398399445,['HSD17B12'],0.9997592994748913,0,0,1
277,"Phase I biotransformations, non P450 WP136",0.5993517650455329,1.245721271393643,0.6376929398399445,['CES2'],0.9997592994748913,0,0,1
278,SARS-CoV-2 and COVID-19 Pathway WP4846,0.5993517650455329,1.245721271393643,0.6376929398399445,['CTSL'],0.9997592994748913,0,0,1
279,TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer WP2868,0.5993517650455329,1.245721271393643,0.6376929398399445,['MAPK3'],0.9997592994748913,0,0,1
280,Tgif disruption of Shh signaling WP3674,0.5993517650455329,1.245721271393643,0.6376929398399445,['GLI3'],0.9997592994748913,0,0,1
281,Vitamin D Metabolism WP1531,0.5993517650455329,1.245721271393643,0.6376929398399445,['RXRB'],0.9997592994748913,0,0,1
282,miRNAs involvement in the immune response in sepsis WP4329,0.5996211860561199,0.9964926590538336,0.5096633250199407,"['NFKBIA', 'TAB2', 'NFKB1']",0.9997592994748913,0,0,3
283,Vitamin D in inflammatory diseases WP4482,0.5996211860561199,0.9964926590538336,0.5096633250199407,"['NFKBIA', 'PPP3CA', 'NFKB1']",0.9997592994748913,0,0,3
284,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.6007745048667525,0.9642645451072854,0.49132712776414306,"['MAPK10', 'YWHAQ', 'MAP4K5', 'TEAD1', 'MAP4K3', 'ACTG1']",0.9997592994748913,0,0,6
285,Alpha 6 Beta 4 signaling pathway WP244,0.6094328408722756,0.9580847723704866,0.47446899092433936,"['GAB1', 'LAMC1', 'RAC1', 'HRAS', 'MAPK3']",0.9997592994748913,0,0,5
286,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.6094328408722756,0.9580847723704866,0.47446899092433936,"['LDHA', 'IGFBP3', 'PGK1', 'BAX', 'HIF1AN']",0.9997592994748913,0,0,5
287,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.6127625281734684,0.9488781209255259,0.4647394489417582,"['NFKBIA', 'MAPK10', 'OTUD5', 'TRADD', 'ISG15', 'FADD', 'NFKB1', 'NFKBIB']",0.9997592994748913,0,0,8
288,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.619637494548876,0.9424682034976153,0.4510847518435983,"['TGFBR3', 'STAT1', 'HRAS', 'RUNX2', 'NFKB1', 'MAPK3', 'FBN1']",0.9997592994748913,0,0,7
289,Dopaminergic Neurogenesis WP2855,0.6204988230893589,0.9964940888707705,0.4755584395764628,"['SOX2', 'ASCL1']",0.9997592994748913,0,0,2
290,Genes targeted by miRNAs in adipocytes WP1992,0.6204988230893589,0.9964940888707705,0.4755584395764628,"['TMSB4X', 'KCNJ2']",0.9997592994748913,0,0,2
291,Signal transduction through IL1R WP4496,0.621087415776289,0.9489615511647336,0.45197467278502934,"['NFKBIA', 'TOLLIP', 'IL1RAP', 'NFKB1']",0.9997592994748913,0,0,4
292,Integrated Cancer Pathway WP1971,0.6281069115262793,0.9340547162106982,0.4343773687559241,"['MRE11', 'CDKN1B', 'POU2F1', 'STAT1', 'BAX', 'BBC3']",0.9997592994748913,0,0,6
293,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.6379337571514898,0.9341353996737357,0.4199133201415035,"['BAX', 'FADD', 'BBC3']",0.9997592994748913,0,0,3
294,Mitochondrial Gene Expression WP391,0.6379337571514898,0.9341353996737357,0.4199133201415035,"['PPP3CA', 'TFAM', 'HCFC1']",0.9997592994748913,0,0,3
295,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.6379337571514898,0.9341353996737357,0.4199133201415035,"['ITPR1', 'HRAS', 'MAPK3']",0.9997592994748913,0,0,3
296,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.6379337571514898,0.9341353996737357,0.4199133201415035,"['RAP1A', 'BRAF', 'MAPK3']",0.9997592994748913,0,0,3
297,Triacylglyceride synthesis WP325,0.6379337571514898,0.9341353996737357,0.4199133201415035,"['DGAT2', 'AGPAT1', 'PLPP1']",0.9997592994748913,0,0,3
298,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.6388833635624941,0.9225245653817082,0.41332179076724485,"['NTRK2', 'GABRB1', 'PIK3CA', 'GABRA4', 'AP2B1']",0.9997592994748913,0,0,5
299,Ectoderm Differentiation WP2858,0.6435822809176794,0.9337299958965942,0.41149984708140785,"['SMURF1', 'CTNND2', 'ARX', 'HMGB2', 'LDB2', 'PTPN13', 'CELSR2', 'GLI3', 'WDR44', 'SOX2', 'PLCXD3', 'MAFB', 'ZNF219', 'ST8SIA4', 'UBTF', 'FGFR2', 'ANKS1B', 'LY6E']",0.9997592994748913,0,0,18
300,Energy Metabolism WP1541,0.644333166146676,0.9175911592707259,0.4033174197977427,"['NCOA1', 'PPP3CA', 'PRMT1', 'PRKAG1', 'TFAM', 'PPARG', 'MEF2D']",0.9997592994748913,0,0,7
301,Genes controlling nephrogenesis WP4823,0.6532213886050214,0.9057527539779682,0.38570500467343627,"['ILK', 'SLIT2', 'GLI3', 'FGFR2']",0.9997592994748913,0,0,4
302,Lipid Metabolism Pathway WP3965,0.6532213886050214,0.9057527539779682,0.38570500467343627,"['PRKAR1A', 'AKT3', 'PRKAG1', 'PRKACA']",0.9997592994748913,0,0,4
303,Nanoparticle-mediated activation of receptor signaling WP2643,0.6532213886050214,0.9057527539779682,0.38570500467343627,"['MAPK10', 'PXN', 'AKT3', 'HRAS']",0.9997592994748913,0,0,4
304,One-carbon metabolism WP241,0.6532213886050214,0.9057527539779682,0.38570500467343627,"['AHCYL2', 'AHCY', 'MTHFD2', 'MAT2B']",0.9997592994748913,0,0,4
305,Trans-sulfuration and one-carbon metabolism WP2525,0.6532213886050214,0.9057527539779682,0.38570500467343627,"['AHCYL2', 'AHCY', 'MTHFD2', 'MAT2B']",0.9997592994748913,0,0,4
306,Tryptophan metabolism WP465,0.6532213886050214,0.9057527539779682,0.38570500467343627,"['ECHS1', 'WARS', 'PRMT1', 'HSD17B10']",0.9997592994748913,0,0,4
307,White fat cell differentiation WP4149,0.6532213886050214,0.9057527539779682,0.38570500467343627,"['WNT10B', 'TLE3', 'DDIT3', 'PPARG']",0.9997592994748913,0,0,4
308,Integrated breast cancer pathway WP1984,0.6630028121319924,0.9253095890809404,0.3802800774297352,"['GSK3A', 'MRE11', 'RALGAPA1', 'GADD45A', 'STAT1', 'ZMYND8', 'TRADD', 'NCOA3', 'ODC1', 'BRAF', 'PHB', 'NFKB1', 'CDC42', 'FER', 'RAP1A', 'CCND1', 'NF1', 'BAX', 'FADD', 'RAC1', 'FAU']",0.9997592994748913,0,0,21
309,GPR40 Pathway WP3958,0.6653529494517557,0.905829596412556,0.36906906219751634,"['PLCL1', 'PLCB1']",0.9997592994748913,0,0,2
310,Major receptors targeted by epinephrine and norepinephrine WP4589,0.6653529494517557,0.905829596412556,0.36906906219751634,"['ADCY8', 'ADRA2A']",0.9997592994748913,0,0,2
311,Matrix Metalloproteinases WP129,0.6653529494517557,0.905829596412556,0.36906906219751634,"['MMP16', 'TIMP2']",0.9997592994748913,0,0,2
312,NOTCH1 regulation of endothelial cell calcification WP3413,0.6653529494517557,0.905829596412556,0.36906906219751634,"['SOX6', 'DLL3']",0.9997592994748913,0,0,2
313,Phytochemical activity on NRF2 transcriptional activation WP3,0.6653529494517557,0.905829596412556,0.36906906219751634,"['PIK3CA', 'KEAP1']",0.9997592994748913,0,0,2
314,Pyrimidine metabolism and related diseases WP4225,0.6653529494517557,0.905829596412556,0.36906906219751634,"['RRM2B', 'TK2']",0.9997592994748913,0,0,2
315,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.6663445889510107,0.9964955175224124,0.40452570257074816,['STAR'],0.9997592994748913,0,0,1
316,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.6663445889510107,0.9964955175224124,0.40452570257074816,['RUNX2'],0.9997592994748913,0,0,1
317,Irinotecan pathway WP229,0.6663445889510107,0.9964955175224124,0.40452570257074816,['CES2'],0.9997592994748913,0,0,1
318,Methylation Pathways WP704,0.6663445889510107,0.9964955175224124,0.40452570257074816,['MAT2B'],0.9997592994748913,0,0,1
319,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.6663445889510107,0.9964955175224124,0.40452570257074816,['HIF1AN'],0.9997592994748913,0,0,1
320,miRNA Biogenesis WP2338,0.6663445889510107,0.9964955175224124,0.40452570257074816,['RAN'],0.9997592994748913,0,0,1
321,Molybdenum cofactor (Moco) biosynthesis WP4507,0.6663445889510107,0.9964955175224124,0.40452570257074816,['SUOX'],0.9997592994748913,0,0,1
322,Somatroph axis (GH) and its relationship to dietary restriction and aging WP4186,0.6663445889510107,0.9964955175224124,0.40452570257074816,['IGF1R'],0.9997592994748913,0,0,1
323,Amyotrophic lateral sclerosis (ALS) WP2447,0.6669142526321131,0.8895043731778426,0.3603327049608076,"['PPP3CA', 'CCS', 'BAX', 'RAC1', 'SOD1']",0.9997592994748913,0,0,5
324,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.6669142526321131,0.8895043731778426,0.3603327049608076,"['NFKBIA', 'PIK3CA', 'STAT1', 'NFKB1', 'MAPK3']",0.9997592994748913,0,0,5
325,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.6766419653898109,0.8980239328163988,0.35077982303563776,"['PPP3CA', 'CAMK2D', 'PIK3CA', 'ROCK2', 'RAC1', 'CALM1', 'PRKG1', 'NFKB1', 'FGFR2', 'IGF1R', 'MAPK3']",0.9997592994748913,0,0,11
326,TGF-beta Receptor Signaling WP560,0.6793586644061008,0.8789662046933923,0.3398136669198082,"['TGFBR3', 'STAT1', 'HRAS', 'RUNX2', 'NFKB1', 'MAPK3']",0.9997592994748913,0,0,6
327,Cardiac Progenitor Differentiation WP2406,0.6834739361889139,0.8663012435030955,0.3296854543113894,"['SOX2', 'MESP1', 'BMP1', 'THY1']",0.9997592994748913,0,0,4
328,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.6834739361889139,0.8663012435030955,0.3296854543113894,"['RAP1A', 'YWHAQ', 'RAC1', 'TEAD1']",0.9997592994748913,0,0,4
329,Adipogenesis WP236,0.6873079086088235,0.899837053130555,0.3374145040688765,"['NCOA1', 'GDF10', 'WNT10B', 'NCOA2', 'MBNL1', 'GADD45A', 'STAT1', 'MIF', 'BSCL2', 'BMP2', 'BMP1', 'DDIT3', 'NDN', 'PPARG', 'MEF2D']",0.9997592994748913,0,0,15
330,B Cell Receptor Signaling Pathway WP23,0.6879966873503224,0.8918567213054661,0.3335287782013428,"['NFKBIA', 'CDC42', 'KLF11', 'GSK3A', 'CD81', 'GAB1', 'BRAF', 'RAC1', 'ILF2', 'HRAS', 'MEF2D', 'NFKB1']",0.9997592994748913,0,0,12
331,Breast cancer pathway WP4262,0.6883064772871154,0.9052113254000821,0.3381155110444228,"['NCOA1', 'WNT10B', 'MRE11', 'GADD45A', 'NCOA3', 'BRAF', 'IGF1R', 'DLL3', 'FRAT2', 'CDK6', 'CCND1', 'PIK3CA', 'AKT3', 'CSNK2B', 'BAX', 'HRAS', 'SKP1', 'MAPK3']",0.9997592994748913,0,0,18
332,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.6907916063604909,0.8715686274509804,0.32240812464151347,"['NTRK2', 'PIK3CA', 'AKT3', 'PRKAG1', 'NF1', 'HRAS', 'MAPK3']",0.9997592994748913,0,0,7
333,PI3K-Akt signaling pathway WP4172,0.6930426123611745,0.925265284237565,0.3392612777096838,"['CDKN1B', 'CHRM1', 'HSP90AB1', 'LAMC1', 'EFNA5', 'IGF1R', 'HSP90B1', 'GHR', 'GNG10', 'GNG3', 'CCND2', 'CCND1', 'GNG4', 'AKT3', 'PDGFC', 'RAC1', 'HRAS', 'EIF4B', 'MAPK3', 'NTRK2', 'HSP90AA1', 'PPP2R5B', 'NFKB1', 'CREB3', 'CDK6', 'COL4A2', 'PIK3CA', 'COL4A1', 'PPP2R2B', 'CDC37', 'ITGA10', 'GNB1', 'GNB5', 'FGF12', 'FGFR2', 'ATF4', 'IFNAR1']",0.9997592994748913,0,0,37
334,Target Of Rapamycin (TOR) Signaling WP1471,0.6934785771685085,0.8587614356087262,0.3143366824792779,"['CDC42', 'RRAGA', 'PRKAG1', 'RICTOR', 'RAC1']",0.9997592994748913,0,0,5
335,Histone Modifications WP2369,0.703190787779586,0.8537828851426238,0.3006400342774841,"['SETD5', 'SET', 'H3F3B', 'SMYD5', 'H3F3A', 'HIST1H4C']",0.9997592994748913,0,0,6
336,Differentiation of white and brown adipocyte WP2895,0.7058219672787408,0.8302758526973774,0.2892616676949145,"['BMP2', 'PPARG']",0.9997592994748913,0,0,2
337,ERK Pathway in Huntington's Disease WP3853,0.7058219672787408,0.8302758526973774,0.2892616676949145,"['NTRK2', 'HRAS']",0.9997592994748913,0,0,2
338,Fatty acid transporters WP5061,0.7058219672787408,0.8302758526973774,0.2892616676949145,"['FABP5', 'FABP6']",0.9997592994748913,0,0,2
339,GDNF/RET signaling axis WP4830,0.7058219672787408,0.8302758526973774,0.2892616676949145,"['SLIT2', 'GLI3']",0.9997592994748913,0,0,2
340,IL-9 signaling pathway WP22,0.7058219672787408,0.8302758526973774,0.2892616676949145,"['STAT1', 'MAPK3']",0.9997592994748913,0,0,2
341,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.7058219672787408,0.8302758526973774,0.2892616676949145,"['LDHA', 'PIK3CA']",0.9997592994748913,0,0,2
342,Serotonin and anxiety WP3947,0.7058219672787408,0.8302758526973774,0.2892616676949145,"['PPP3CA', 'CRH']",0.9997592994748913,0,0,2
343,Angiogenesis WP1539,0.7065955997748362,0.8302066340402393,0.2883280835951166,"['PIK3CA', 'TIMP2', 'FGFR2']",0.9997592994748913,0,0,3
344,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.7065955997748362,0.8302066340402393,0.2883280835951166,"['BMP2', 'ASCL1', 'SOX6']",0.9997592994748913,0,0,3
345,TLR4 Signaling and Tolerance WP3851,0.7065955997748362,0.8302066340402393,0.2883280835951166,"['NFKBIA', 'TAB2', 'NFKB1']",0.9997592994748913,0,0,3
346,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.711817897107978,0.8301373589011288,0.2821912179462559,"['NFKBIA', 'STAT1', 'NFKB1', 'IFNAR1']",0.9997592994748913,0,0,4
347,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.711817897107978,0.8301373589011288,0.2821912179462559,"['CDKN1B', 'PIK3CA', 'RICTOR', 'HRAS']",0.9997592994748913,0,0,4
348,Glucocorticoid Receptor Pathway WP2880,0.7124886199939727,0.8502411127052447,0.28822437318817085,"['TGFBR3', 'FGD4', 'RGS2', 'HSP90AA1', 'NAV3', 'PLK2', 'PTGES3']",0.9997592994748913,0,0,7
349,Focal Adhesion WP306,0.7136648237787365,0.9016222341504145,0.3041549226983177,"['ROCK2', 'PXN', 'ILK', 'LAMC1', 'MYL12B', 'ACTG1', 'IGF1R', 'CDC42', 'CCND2', 'RAP1A', 'CCND1', 'AKT3', 'PDGFC', 'RAC3', 'RAC1', 'HRAS', 'MAPK3', 'VAV3', 'BRAF', 'MAPK10', 'COL4A2', 'PIK3CA', 'COL4A1', 'ITGA10', 'VCL']",0.9997592994748913,0,0,25
350,ErbB signaling pathway WP673,0.7146925221176528,0.8746375367996989,0.29379325687704816,"['CAMK2D', 'CDKN1B', 'GAB1', 'CBLB', 'BRAF', 'MAPK10', 'CCND1', 'NRG3', 'PIK3CA', 'ERBB4', 'AKT3', 'HRAS', 'MAPK3']",0.9997592994748913,0,0,13
351,Osteoblast differentiation WP4787,0.7146925221176528,0.8746375367996989,0.29379325687704816,"['WNT10B', 'STAT1', 'RUNX2', 'GLI3', 'DLL3', 'MAPK10', 'BMP2', 'PIK3CA', 'PPARG', 'PRKD1', 'MAPK6', 'FGFR2', 'MAPK3']",0.9997592994748913,0,0,13
352,Vitamin D Receptor Pathway WP2877,0.7146925221176528,0.8746375367996989,0.29379325687704816,"['CDKN2D', 'CDKN1B', 'GADD45A', 'IGFBP3', 'G0S2', 'EFNA5', 'SFRP1', 'CCND1', 'ADGRE5', 'PNOC', 'CREG2', 'TIMP2', 'CD200']",0.9997592994748913,0,0,13
353,Oncostatin M Signaling Pathway WP2374,0.7213482999579478,0.8475858411080872,0.2768496580478746,"['NFKBIA', 'CDKN1B', 'STAT1', 'PXN', 'RICTOR', 'HRAS', 'NFKB1', 'MAPK3']",0.9997592994748913,0,0,8
354,Aspirin and miRNAs WP4707,0.7221392260363438,0.830345014941592,0.2703082948533464,['NFKB1'],0.9997592994748913,0,0,1
355,"Cerebral organic acidurias, including diseases WP4519",0.7221392260363438,0.830345014941592,0.2703082948533464,['MDH2'],0.9997592994748913,0,0,1
356,DDX1 as a regulatory component of the Drosha microprocessor WP2942,0.7221392260363438,0.830345014941592,0.2703082948533464,['MRE11'],0.9997592994748913,0,0,1
357,Glial Cell Differentiation WP2276,0.7221392260363438,0.830345014941592,0.2703082948533464,['TPPP'],0.9997592994748913,0,0,1
358,Insulin signaling in adipocytes (diabetic condition) WP3635,0.7221392260363438,0.830345014941592,0.2703082948533464,['TBC1D4'],0.9997592994748913,0,0,1
359,Insulin signaling in adipocytes (normal condition) WP3634,0.7221392260363438,0.830345014941592,0.2703082948533464,['TBC1D4'],0.9997592994748913,0,0,1
360,LDLRAD4 and what we know about it WP4904,0.7221392260363438,0.830345014941592,0.2703082948533464,['LDLRAD4'],0.9997592994748913,0,0,1
361,Liver X receptor pathway WP2874,0.7221392260363438,0.830345014941592,0.2703082948533464,['ABCG8'],0.9997592994748913,0,0,1
362,LTF danger signal response pathway WP4478,0.7221392260363438,0.830345014941592,0.2703082948533464,['NFKB1'],0.9997592994748913,0,0,1
363,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.7221392260363438,0.830345014941592,0.2703082948533464,['BAX'],0.9997592994748913,0,0,1
364,Mevalonate pathway WP3963,0.7221392260363438,0.830345014941592,0.2703082948533464,['PMVK'],0.9997592994748913,0,0,1
365,NAD Biosynthesis II (from tryptophan) WP2485,0.7221392260363438,0.830345014941592,0.2703082948533464,['QPRT'],0.9997592994748913,0,0,1
366,Role of Osx and miRNAs in tooth development WP3971,0.7221392260363438,0.830345014941592,0.2703082948533464,['RUNX2'],0.9997592994748913,0,0,1
367,Sulfation Biotransformation Reaction WP692,0.7221392260363438,0.830345014941592,0.2703082948533464,['SULT4A1'],0.9997592994748913,0,0,1
368,Type III interferon signaling WP2113,0.7221392260363438,0.830345014941592,0.2703082948533464,['STAT1'],0.9997592994748913,0,0,1
369,Corticotropin-releasing hormone signaling pathway WP2355,0.7292412396365058,0.855718085106383,0.27019356995303295,"['NFKBIA', 'NCOA2', 'HSP90AA1', 'STAR', 'GNB1', 'CRH', 'BRAF', 'GNB5', 'NFKB1', 'GNAI2', 'MAPK3']",0.9997592994748913,0,0,11
370,Wnt signaling WP428,0.7302740210914869,0.8629047229047229,0.2712415391312118,"['WNT10B', 'CAMK2D', 'ROCK2', 'NKD1', 'PPP3CA', 'SFRP1', 'CCND2', 'FRAT2', 'CCND1', 'CSNK2B', 'ROR1', 'RAC1', 'PLCB1']",0.9997592994748913,0,0,13
371,Interferon type I signaling pathways WP585,0.7331386067688932,0.8299291938997821,0.25762703515990326,"['RAP1A', 'PRMT1', 'STAT1', 'RACK1', 'RAC1', 'EIF4B', 'IFNAR1']",0.9997592994748913,0,0,7
372,EPO Receptor Signaling WP581,0.736971244646066,0.7864471537735039,0.24002870798810594,"['STAT1', 'RASA1', 'MAPK3']",0.9997592994748913,0,0,3
373,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.7378117158461802,0.8438528993795709,0.2565874942604339,"['WNT10B', 'CDK8', 'SFRP1', 'CCND2', 'FRAT2', 'CDK6', 'CCND1', 'CSNK2B', 'ROR1', 'NKD1']",0.9997592994748913,0,0,10
374,Autophagy WP4923,0.7382552929047842,0.7968665850673194,0.24182158747617247,"['MAP1LC3B', 'ATG9A', 'PRKAG1', 'WIPI2']",0.9997592994748913,0,0,4
375,Melatonin metabolism and effects WP3298,0.7382552929047842,0.7968665850673194,0.24182158747617247,"['CRY2', 'CRY1', 'CALM1', 'NFKB1']",0.9997592994748913,0,0,4
376,MAPK pathway in congenital thyroid cancer WP4928,0.7421180325955434,0.766345761861457,0.22856030519243617,"['BRAF', 'MAPK3']",0.9997592994748913,0,0,2
377,PPAR-alpha pathway WP2878,0.7421180325955434,0.766345761861457,0.22856030519243617,"['CCND1', 'APOA1']",0.9997592994748913,0,0,2
378,SARS coronavirus and innate immunity WP4912,0.7421180325955434,0.766345761861457,0.22856030519243617,"['STAT1', 'IFNAR1']",0.9997592994748913,0,0,2
379,Ferroptosis WP4313,0.7421252017970199,0.8032258064516129,0.23955190743194363,"['MAP1LC3B', 'MAP1LC3A', 'GPX4', 'VDAC2', 'SLC3A2']",0.9997592994748913,0,0,5
380,NO/cGMP/PKG mediated Neuroprotection WP4008,0.7421252017970199,0.8032258064516129,0.23955190743194363,"['NFKBIA', 'CAMK2D', 'CYCS', 'CALM1', 'NFKB1']",0.9997592994748913,0,0,5
381,Hippo-Merlin Signaling Dysregulation WP4541,0.7452978828821168,0.8514806672701409,0.2503108767439758,"['NTRK2', 'ITGAE', 'IGF1R', 'DDB1', 'CCND1', 'CDH2', 'PRKAR1A', 'ITGA10', 'PRKACA', 'HRAS', 'TEAD1', 'FGFR2', 'CDH18']",0.9997592994748913,0,0,13
382,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.7471619033569252,0.8075000275898602,0.2353647617769444,"['BANF1', 'ADCY8', 'LEMD3', 'HRAS', 'EMD', 'MAPK3']",0.9997592994748913,0,0,6
383,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.7642112216300238,0.7780612244897959,0.20922926856312532,"['STAT1', 'TRADD', 'FADD', 'NFKB1', 'IFNAR1']",0.9997592994748913,0,0,5
384,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.7647977327134325,0.7470636215334421,0.20032053942780698,"['CBX5', 'H3F3B', 'H3F3A']",0.9997592994748913,0,0,3
385,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.7647977327134325,0.7470636215334421,0.20032053942780698,"['PIK3CA', 'CBLB', 'NFKB1']",0.9997592994748913,0,0,3
386,Sleep regulation WP3591,0.7647977327134325,0.7470636215334421,0.20032053942780698,"['AHCY', 'STAR', 'CRH']",0.9997592994748913,0,0,3
387,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.7672973126300031,0.7861855537168769,0.20824555447044754,"['NFKBIA', 'DLG1', 'PIK3CA', 'CALM1', 'NFKB1', 'MAPK3']",0.9997592994748913,0,0,6
388,ATR Signaling WP3875,0.7686068716244872,0.7116660845267202,0.1872931918140197,['ATRIP'],0.9997592994748913,0,0,1
389,Autosomal recessive Osteopetrosis pathways WP4788,0.7686068716244872,0.7116660845267202,0.1872931918140197,['NFKB1'],0.9997592994748913,0,0,1
390,Cell Differentiation - Index WP2029,0.7686068716244872,0.7116660845267202,0.1872931918140197,['MEF2D'],0.9997592994748913,0,0,1
391,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.7686068716244872,0.7116660845267202,0.1872931918140197,['STAT1'],0.9997592994748913,0,0,1
392,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.7686068716244872,0.7116660845267202,0.1872931918140197,['CCND1'],0.9997592994748913,0,0,1
393,Mitochondrial CII Assembly WP4920,0.7686068716244872,0.7116660845267202,0.1872931918140197,['SDHAF1'],0.9997592994748913,0,0,1
394,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.7686068716244872,0.7116660845267202,0.1872931918140197,['NFKB1'],0.9997592994748913,0,0,1
395,Valproic acid pathway WP3871,0.7686068716244872,0.7116660845267202,0.1872931918140197,['HSD17B10'],0.9997592994748913,0,0,1
396,DNA IR-double strand breaks and cellular response via ATM WP3959,0.771278655560814,0.7920751633986928,0.20570631575756643,"['UPF1', 'MRE11', 'PCNA', 'KAT5', 'NABP2', 'BAX', 'MCPH1']",0.9997592994748913,0,0,7
397,Globo Sphingolipid Metabolism WP1424,0.7745049053447005,0.7115485411449537,0.18182291347281498,"['B3GALNT1', 'ST8SIA1']",0.9997592994748913,0,0,2
398,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.7745049053447005,0.7115485411449537,0.18182291347281498,"['BMP2', 'CDC37']",0.9997592994748913,0,0,2
399,Cell cycle WP179,0.7796327511610076,0.8294414857298921,0.2064747784331987,"['CDKN2D', 'CDKN1B', 'PCNA', 'GADD45A', 'YWHAB', 'ANAPC11', 'STAG1', 'CCND2', 'CDK6', 'CCND1', 'YWHAQ', 'MCM4', 'MCM6', 'SKP1']",0.9997592994748913,0,0,14
400,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.7804559403453342,0.8000233617568041,0.19830738377841975,"['CDK8', 'GSK3A', 'RBP4', 'SEC24B', 'PIK3CA', 'PRKAG1', 'PPARG', 'PRKACA', 'KPNB1']",0.9997592994748913,0,0,9
401,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.7851417045149298,0.8760264781606538,0.21190297530447652,"['CDKN1B', 'CHRM1', 'HSP90AB1', 'CAB39L', 'ITGAE', 'LAMC1', 'EFNA5', 'IGF1R', 'HSP90B1', 'GHR', 'GNG10', 'GNG3', 'GNG4', 'AKT3', 'PDGFC', 'HRAS', 'EIF4B', 'MAPK3', 'HSP90AA1', 'PPP2R5B', 'CREB3', 'COL4A2', 'PIK3CA', 'RAB14', 'PIK3IP1', 'COL4A1', 'PPP2R2B', 'CDC37', 'ITGA10', 'GNB1', 'FGF12', 'FGFR2', 'ATF4', 'IFNAR1']",0.9997592994748913,0,0,34
402,Retinoblastoma gene in cancer WP2446,0.7852824016074313,0.8028234052378125,0.19405195348226445,"['CDKN1B', 'PCNA', 'CDK6', 'CCND1', 'PRMT2', 'H2AFZ', 'STMN1', 'HMGB2', 'MCM4', 'MCM6']",0.9997592994748913,0,0,10
403,BDNF-TrkB Signaling WP3676,0.7855352841102249,0.7377185426961029,0.17807780745917806,"['NTRK2', 'GAB1', 'BRAF', 'HRAS']",0.9997592994748913,0,0,4
404,MAPK Cascade WP422,0.7855352841102249,0.7377185426961029,0.17807780745917806,"['MAPK10', 'BRAF', 'HRAS', 'MAPK3']",0.9997592994748913,0,0,4
405,Vitamin A and carotenoid metabolism WP716,0.7855352841102249,0.7377185426961029,0.17807780745917806,"['RXRB', 'ABCG8', 'RBP4', 'CRABP1']",0.9997592994748913,0,0,4
406,Monoamine GPCRs WP58,0.790178292037624,0.7114309018876719,0.1675396103648888,"['CHRM1', 'HTR5A', 'ADRA2A']",0.9997592994748913,0,0,3
407,Vitamin B12 metabolism WP1533,0.790178292037624,0.7114309018876719,0.1675396103648888,"['APOA1', 'NFKB1', 'SOD1']",0.9997592994748913,0,0,3
408,AMP-activated protein kinase (AMPK) signaling WP1403,0.7920425930775513,0.7808521038165982,0.1820479449679253,"['PIK3CA', 'PRKAG1', 'LEPR', 'PLCB1', 'ADIPOR1', 'EEF2', 'CPT1B', 'ACACB']",0.9997592994748913,0,0,8
409,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.7920425930775513,0.7808521038165982,0.1820479449679253,"['CDKN1B', 'PCNA', 'YWHAQ', 'CDH2', 'CTSL', 'FAT1', 'ILK', 'VCL']",0.9997592994748913,0,0,8
410,T-cell receptor (TCR) signaling pathway WP69,0.7957208077718165,0.7859233119593751,0.17958889860677887,"['VAV3', 'CDC42', 'NFKBIA', 'CD83', 'ITPR1', 'CBLB', 'HRAS', 'NFKB1', 'MAPK3']",0.9997592994748913,0,0,9
411,Imatinib and Chronic Myeloid Leukemia WP3640,0.8032747837693704,0.6640576165239842,0.1454674169770643,"['CDKN1B', 'GADD45A']",0.9997592994748913,0,0,2
412,IL-2 signaling pathway WP49,0.8064855267745691,0.7113131666375241,0.15298164424885652,"['CCND2', 'STAT1', 'HRAS', 'MAPK3']",0.9997592994748913,0,0,4
413,Biotin Metabolism (including IEMs) WP5031,0.8073061541180526,0.6226568867155664,0.13328114464207033,['ACACB'],0.9997592994748913,0,0,1
414,Blood Clotting Cascade WP272,0.8073061541180526,0.6226568867155664,0.13328114464207033,['KLKB1'],0.9997592994748913,0,0,1
415,Estrogen Receptor Pathway WP2881,0.8073061541180526,0.6226568867155664,0.13328114464207033,['ACOX1'],0.9997592994748913,0,0,1
416,Farnesoid X receptor pathway WP2879,0.8073061541180526,0.6226568867155664,0.13328114464207033,['SLC27A5'],0.9997592994748913,0,0,1
417,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.8073061541180526,0.6226568867155664,0.13328114464207033,['APOA1'],0.9997592994748913,0,0,1
418,Vitamin B12 Disorders WP4271,0.8073061541180526,0.6226568867155664,0.13328114464207033,['CD320'],0.9997592994748913,0,0,1
419,Regulatory circuits of the STAT3 signaling pathway WP4538,0.8074434149706022,0.7657728458709252,0.1637852580734954,"['GHR', 'PTPRD', 'MAPK10', 'STMN1', 'RICTOR', 'MAPK6', 'IFNAR1', 'MAPK3']",0.9997592994748913,0,0,8
420,Thermogenesis WP4321,0.81193985619232,0.7985915208137431,0.16636978115899195,"['PRKAG1', 'ADCY8', 'CPT1B', 'ARID1B', 'ACTG1', 'CREB3', 'RPS6KA6', 'ZNF516', 'PPARG', 'PRKACA', 'HRAS', 'PRKG1', 'MGLL']",0.9997592994748913,0,0,13
421,Glycosylation and related congenital defects WP4521,0.8132361011192877,0.6790375203915171,0.14038000986218624,"['DPM2', 'DPM3', 'MPI']",0.9997592994748913,0,0,3
422,22q11.2 copy number variation syndrome WP4657,0.8200543986428644,0.7856604261369757,0.1558629302516964,"['CDC42', 'RANBP1', 'CBX5', 'MRPL40', 'HIRIP3', 'TXNRD2', 'EMC10', 'HIST1H4C', 'KPNB1', 'FGFR2', 'RAN', 'DGCR2']",0.9997592994748913,0,0,12
423,IL-3 signaling pathway WP286,0.8218359301752148,0.7111953352769679,0.13954683866079676,"['YWHAQ', 'YWHAB', 'PRKACA', 'HRAS', 'MAPK3']",0.9997592994748913,0,0,5
424,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.8287314360495562,0.622503057480636,0.1169428875772121,"['MDH2', 'IDH3B']",0.9997592994748913,0,0,2
425,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.8287314360495562,0.622503057480636,0.1169428875772121,"['STAT1', 'IFNAR1']",0.9997592994748913,0,0,2
426,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.8356178707267677,0.737289803084654,0.1324053508617276,"['WNT10B', 'SFRP1', 'FRAT2', 'CCND2', 'CCND1', 'CSNK2B', 'ROR1', 'NKD1']",0.9997592994748913,0,0,8
427,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.835924848353272,0.7110774076882692,0.12743684992342277,"['WNT10B', 'BMP2', 'PPARG', 'LEMD3', 'EMD', 'RUNX2']",0.9997592994748913,0,0,6
428,Wnt Signaling Pathway WP363,0.835924848353272,0.7110774076882692,0.12743684992342277,"['GSK3A', 'CDK6', 'CCND1', 'PPARG', 'ROR1', 'RAC1']",0.9997592994748913,0,0,6
429,MAPK Signaling Pathway WP382,0.8379272015050804,0.8377620757558207,0.14813648651081565,"['CDC42', 'PPP3CA', 'RAP1A', 'STMN1', 'AKT3', 'RAC3', 'RAC1', 'PRKACA', 'HRAS', 'MAP4K3', 'MAPK3', 'HSPA8', 'NTRK2', 'DUSP3', 'GADD45A', 'PLA2G4C', 'BRAF', 'HSPA2', 'NFKB1', 'MAPK10', 'MRAS', 'CACNB4', 'DDIT3', 'RASA1', 'NF1', 'RAPGEF2', 'TAB2', 'FGF12', 'FGFR2', 'ATF4']",0.9997592994748913,0,0,30
430,Cancer immunotherapy by CTLA4 blockade WP4582,0.8395353292190342,0.5534275106402246,0.09679819048122593,['PIK3CA'],0.9997592994748913,0,0,1
431,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.8395353292190342,0.5534275106402246,0.09679819048122593,['PMVK'],0.9997592994748913,0,0,1
432,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.8395353292190342,0.5534275106402246,0.09679819048122593,['MAPK3'],0.9997592994748913,0,0,1
433,Non-homologous end joining WP438,0.8395353292190342,0.5534275106402246,0.09679819048122593,['XRCC6'],0.9997592994748913,0,0,1
434,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.8395353292190342,0.5534275106402246,0.09679819048122593,['NFKB1'],0.9997592994748913,0,0,1
435,Endoderm differentiation WP2853,0.840846251318479,0.7853968938740293,0.136145765144059,"['VAV3', 'STAT1', 'CTR9', 'LAMC1', 'TRERF1', 'NME1', 'SOX2', 'SFRP1', 'SESN1', 'TCEAL2', 'UBR5', 'NABP2', 'CEBPZ', 'ASCC3', 'TOX']",0.9997592994748913,0,0,15
436,Vitamin D-sensitive calcium signaling in depression WP4698,0.8433710895825149,0.6637834897320821,0.11307433373409684,"['GRM5', 'CHRM1', 'GPX4', 'ITPR1']",0.9997592994748913,0,0,4
437,Neural Crest Differentiation WP2064,0.8484365206838013,0.7238250919493256,0.11896789984248413,"['CDH2', 'HDAC11', 'MITF', 'ASCL1', 'NFKB1', 'FGFR2', 'RHOB', 'DLL3']",0.9997592994748913,0,0,8
438,Kallmann's Syndrome WP5074,0.8511781739960003,0.5858372700894463,0.09439818678567007,"['PIK3CA', 'ASCL1']",0.9997592994748913,0,0,2
439,Ovarian infertility WP34,0.8511781739960003,0.5858372700894463,0.09439818678567007,"['CDKN1B', 'CCND2']",0.9997592994748913,0,0,2
440,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.8511781739960003,0.5858372700894463,0.09439818678567007,"['GSTP1', 'KEAP1']",0.9997592994748913,0,0,2
441,Statin inhibition of cholesterol production WP430,0.8511781739960003,0.5858372700894463,0.09439818678567007,"['ABCG8', 'APOA1']",0.9997592994748913,0,0,2
442,Pre-implantation embryo WP3527,0.8529367102857406,0.6223491027732463,0.09899702874899448,"['SOX2', 'DDIT3', 'ATP1A1']",0.9997592994748913,0,0,3
443,ATM Signaling Network in Development and Disease  WP3878,0.8535197687356084,0.672642029784887,0.10653746733409468,"['MRE11', 'KAT5', 'ATMIN', 'NFKB1', 'HMGN1']",0.9997592994748913,0,0,5
444,Netrin-UNC5B signaling pathway WP4747,0.8594768739480462,0.642318474355431,0.0972671607173449,"['ARHGEF12', 'PIK3CA', 'RAC1', 'MAPK3']",0.9997592994748913,0,0,4
445,Development and heterogeneity of the ILC family WP3893,0.8663757607633819,0.4980440097799511,0.07143771981265973,['TOX'],0.9997592994748913,0,0,1
446,Ganglio Sphingolipid Metabolism WP1423,0.8663757607633819,0.4980440097799511,0.07143771981265973,['ST8SIA1'],0.9997592994748913,0,0,1
447,Glutathione metabolism WP100,0.8663757607633819,0.4980440097799511,0.07143771981265973,['GPX4'],0.9997592994748913,0,0,1
448,Inflammatory Response Pathway WP453,0.8663757607633819,0.4980440097799511,0.07143771981265973,['LAMC1'],0.9997592994748913,0,0,1
449,Leptin Insulin Overlap WP3935,0.8663757607633819,0.4980440097799511,0.07143771981265973,['LEPR'],0.9997592994748913,0,0,1
450,Neuroinflammation WP4919,0.8663757607633819,0.4980440097799511,0.07143771981265973,['NFKBIA'],0.9997592994748913,0,0,1
451,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.8663757607633819,0.4980440097799511,0.07143771981265973,['ADAR'],0.9997592994748913,0,0,1
452,Peptide GPCRs WP24,0.869870929349982,0.5974061990212072,0.08328465832127895,"['OPRD1', 'NPY1R', 'NMBR']",0.9997592994748913,0,0,3
453,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.869870929349982,0.5974061990212072,0.08328465832127895,"['PIK3CA', 'BAX', 'BRAF']",0.9997592994748913,0,0,3
454,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.8709095208886172,0.5532454590750555,0.07646803113046359,"['PRKACA', 'MAPK3']",0.9997592994748913,0,0,2
455,Monoamine Transport WP727,0.8709095208886172,0.5532454590750555,0.07646803113046359,"['AMPH', 'SLC6A1']",0.9997592994748913,0,0,2
456,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.8709095208886172,0.5532454590750555,0.07646803113046359,"['MDH2', 'SCO2']",0.9997592994748913,0,0,2
457,Striated Muscle Contraction Pathway WP383,0.8709095208886172,0.5532454590750555,0.07646803113046359,"['TPM3', 'ACTG1']",0.9997592994748913,0,0,2
458,Urea cycle and associated pathways WP4595,0.8709095208886172,0.5532454590750555,0.07646803113046359,"['MDH2', 'PYCR1']",0.9997592994748913,0,0,2
459,Mesodermal commitment pathway WP2857,0.8752311448084207,0.7486179205596155,0.09976626056815228,"['VAV3', 'ARID5B', 'TRERF1', 'SOX2', 'CCND1', 'PRKAR1A', 'SESN1', 'UBR5', 'NABP2', 'RPL38', 'ASCC3', 'PRKACA', 'TOX', 'TEAD1']",0.9997592994748913,0,0,14
460,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.8768033982628044,0.7534153005464481,0.09905338333680122,"['WNT10B', 'SPARC', 'EIF5A2', 'DLL3', 'TJP1', 'FMNL2', 'CDH2', 'COL4A2', 'PIK3CA', 'COL4A1', 'AKT3', 'STRAP', 'HRAS', 'MEF2D', 'MAPK3']",0.9997592994748913,0,0,15
461,Insulin Signaling WP481,0.8790504030525121,0.776694045174538,0.10012599174381966,"['XBP1', 'ARF1', 'GSK3A', 'STXBP4', 'STXBP1', 'GAB1', 'CBLB', 'IGF1R', 'MAPK10', 'RPS6KA6', 'TBC1D4', 'PIK3CA', 'RAC1', 'MAP4K5', 'MAPK6', 'HRAS', 'PFKM', 'VAMP2', 'MAP4K3', 'MAPK3']",0.9997592994748913,0,0,20
462,IL-4 signaling pathway WP395,0.8803624858599314,0.6380429094714809,0.08130041047715122,"['NFKBIA', 'PIK3CA', 'STAT1', 'NFKB1', 'MAPK3']",0.9997592994748913,0,0,5
463,Genes related to primary cilium development (based on CRISPR) WP4536,0.8823545914027184,0.7346437346437347,0.09194894480860658,"['DYNC2H1', 'C2CD3', 'DYNLT1', 'ARL6', 'ARL3', 'WDR19', 'DYNLL1', 'KIF3B', 'TTC21B', 'TMEM107', 'BBS9', 'KIFAP3', 'IFT57']",0.9997592994748913,0,0,13
464,Pathways affected in adenoid cystic carcinoma WP3651,0.8840701140919499,0.6697775263951734,0.08252925333311312,"['MAGI1', 'PIK3CA', 'MAGI2', 'JMJD1C', 'ARID5B', 'DTX4', 'HRAS']",0.9997592994748913,0,0,7
465,Fatty Acid Biosynthesis WP357,0.8882056753913713,0.5240843650095479,0.062131221537734135,"['ECHS1', 'ACACB']",0.9997592994748913,0,0,2
466,Gastric Cancer Network 1 WP2361,0.8882056753913713,0.5240843650095479,0.062131221537734135,"['H3F3A', 'MCM4']",0.9997592994748913,0,0,2
467,Glycerolipids and Glycerophospholipids WP4722,0.8882056753913713,0.5240843650095479,0.062131221537734135,"['DGAT2', 'CDIPT']",0.9997592994748913,0,0,2
468,NRF2-ARE regulation WP4357,0.8882056753913713,0.5240843650095479,0.062131221537734135,"['PIK3CA', 'KEAP1']",0.9997592994748913,0,0,2
469,Toll-like Receptor Signaling related to MyD88 WP3858,0.8882056753913713,0.5240843650095479,0.062131221537734135,"['TOLLIP', 'NFKB1']",0.9997592994748913,0,0,2
470,FOXA2 pathway WP5066,0.8887281433462304,0.45273023634881826,0.053405820137686966,['SLC27A5'],0.9997592994748913,0,0,1
471,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.8887281433462304,0.45273023634881826,0.053405820137686966,['NFKB1'],0.9997592994748913,0,0,1
472,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.8887281433462304,0.45273023634881826,0.053405820137686966,['DKK3'],0.9997592994748913,0,0,1
473,Prader-Willi and Angelman Syndrome WP3998,0.8921309116814543,0.6220408163265306,0.07100122868511573,"['CCND2', 'CDK6', 'CCND1', 'FEZ1', 'NDN']",0.9997592994748913,0,0,5
474,Allograft Rejection WP2328,0.8995462103105799,0.585499316005472,0.06198379936060204,"['STAT1', 'HLA-B', 'HLA-A', 'HLA-F']",0.9997592994748913,0,0,4
475,Interleukin-11 Signaling Pathway WP2332,0.8995462103105799,0.585499316005472,0.06198379936060204,"['STAT1', 'HRAS', 'RUNX2', 'MAPK3']",0.9997592994748913,0,0,4
476,7-oxo-C and 7beta-HC pathways WP5064,0.9033290710373547,0.4978393803505911,0.05061451941554106,"['DBP', 'SLC27A5']",0.9997592994748913,0,0,2
477,Omega-3/Omega-6 FA synthesis WP4723,0.9073426773223315,0.4149687584895409,0.04034952299951521,['ACOX1'],0.9997592994748913,0,0,1
478,Tryptophan catabolism leading to NAD+ production WP4210,0.9073426773223315,0.4149687584895409,0.04034952299951521,['QPRT'],0.9997592994748913,0,0,1
479,Amino Acid metabolism WP3925,0.9093968415420949,0.652307609853484,0.061952074238739455,"['LDHA', 'WARS', 'PPM1L', 'MDH2', 'ODC1', 'PYCR1', 'GLS', 'SRM']",0.9997592994748913,0,0,8
480,16p11.2 distal deletion syndrome WP4950,0.9165224848803966,0.47409391804010637,0.04132614035944338,"['CD81', 'PRMT1']",0.9997592994748913,0,0,2
481,Fatty acid beta-oxidation WP143,0.9215451741502673,0.5148365866006638,0.04206394109865948,"['ECHS1', 'ACADL', 'CPT1B']",0.9997592994748913,0,0,3
482,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.9228442060319162,0.38301673876246,0.030754271429663235,['MADD'],0.9997592994748913,0,0,1
483,Hypertrophy Model WP516,0.9228442060319162,0.38301673876246,0.030754271429663235,['WDR1'],0.9997592994748913,0,0,1
484,Kennedy pathway from sphingolipids WP3933,0.9228442060319162,0.38301673876246,0.030754271429663235,['SGPL1'],0.9997592994748913,0,0,1
485,Mammalian disorder of sexual development WP4842,0.9228442060319162,0.38301673876246,0.030754271429663235,['FGFR2'],0.9997592994748913,0,0,1
486,Riboflavin and CoQ disorders WP5037,0.9228442060319162,0.38301673876246,0.030754271429663235,['FLAD1'],0.9997592994748913,0,0,1
487,Joubert Syndrome WP4656,0.9244173183366762,0.6314956441642179,0.04963029479652442,"['MRE11', 'KAT5', 'CETN2', 'CSPP1', 'ARL3', 'BBS9', 'CEP41', 'ATF4']",0.9997592994748913,0,0,8
488,Metapathway biotransformation Phase I and II WP702,0.924778946906629,0.677855096193205,0.05300863886590519,"['GSTM3', 'AKR7A2', 'GPX4', 'GSTO1', 'NAA20', 'MGST3', 'GSTP1', 'NDST3', 'NAT14', 'SULT4A1', 'HS6ST2', 'HS2ST1']",0.9997592994748913,0,0,12
489,Canonical and non-canonical TGF-B signaling WP3874,0.9357531553069056,0.355629293282105,0.023615051202507367,['BMP1'],0.9997592994748913,0,0,1
490,Cholesterol Biosynthesis Pathway WP197,0.9357531553069056,0.355629293282105,0.023615051202507367,['PMVK'],0.9997592994748913,0,0,1
491,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.9357531553069056,0.355629293282105,0.023615051202507367,['ACOX1'],0.9997592994748913,0,0,1
492,Eicosanoid Synthesis WP167,0.9357531553069056,0.355629293282105,0.023615051202507367,['PTGES2'],0.9997592994748913,0,0,1
493,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.9357531553069056,0.355629293282105,0.023615051202507367,['FGFR2'],0.9997592994748913,0,0,1
494,"GPCRs, Other WP117",0.9371381266763162,0.5236960209581482,0.03400075146994088,"['ADGRV1', 'CELSR2', 'ADGRL2', 'ADGRL3']",0.9997592994748913,0,0,4
495,Wnt signaling in kidney disease WP4150,0.9379884174643388,0.43279746184795903,0.027706688625891738,"['MAPK10', 'WNT10B']",0.9997592994748913,0,0,2
496,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.9383728838183053,0.5738606024436976,0.03650205533108972,"['RYR2', 'CACNB4', 'CDH2', 'ITGA10', 'EMD', 'ACTG1']",0.9997592994748913,0,0,6
497,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9393233774733006,0.6753797385282969,0.04227571493420446,"['ABCG8', 'GSK3A', 'THRA', 'PRKAG1', 'CBLB', 'MAPK10', 'RPS6KA6', 'PIK3CA', 'RICTOR', 'MAP4K5', 'MAPK6', 'HRAS', 'MAP4K3', 'MAPK3']",0.9997592994748913,0,0,14
498,ATM Signaling Pathway WP2516,0.9396183557486552,0.4815423880439931,0.02999117775440568,"['NFKBIA', 'MRE11', 'GADD45A']",0.9997592994748913,0,0,3
499,Bladder cancer WP2828,0.9396183557486552,0.4815423880439931,0.02999117775440568,"['CCND1', 'BRAF', 'HRAS']",0.9997592994748913,0,0,3
500,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.9396183557486552,0.4815423880439931,0.02999117775440568,"['MAPK10', 'DDIT3', 'MAPK3']",0.9997592994748913,0,0,3
501,IL-5 signaling pathway WP127,0.9396183557486552,0.4815423880439931,0.02999117775440568,"['GSK3A', 'STAT1', 'MAPK3']",0.9997592994748913,0,0,3
502,Notch Signaling Pathway Netpath WP61,0.9437341954313231,0.5406388642413487,0.03130878865733172,"['CCND1', 'PSEN2', 'NFKB1', 'SKP1', 'DLL3']",0.9997592994748913,0,0,5
503,MECP2 and Associated Rett Syndrome WP3584,0.9460853160426663,0.5800925925925926,0.032150197900543284,"['PRPF38A', 'SST', 'NF1', 'TAP1', 'YBX1', 'IGF1R', 'GRIA4']",0.9997592994748913,0,0,7
504,Glycosaminoglycan degradation WP4815,0.9465029769098358,0.3318935071991307,0.0182478910713625,['HPSE2'],0.9997592994748913,0,0,1
505,Kynurenine Pathway and links to Cellular Senescence WP5044,0.9465029769098358,0.3318935071991307,0.0182478910713625,['QPRT'],0.9997592994748913,0,0,1
506,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.9465029769098358,0.3318935071991307,0.0182478910713625,['ACADL'],0.9997592994748913,0,0,1
507,Transcription factor regulation in adipogenesis WP3599,0.9465029769098358,0.3318935071991307,0.0182478910713625,['PPARG'],0.9997592994748913,0,0,1
508,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.9466451117591476,0.41473026226389453,0.022740077507997856,"['TGFBR3', 'HRAS']",0.9997592994748913,0,0,2
509,Glycerophospholipid Biosynthetic Pathway WP2533,0.9466451117591476,0.41473026226389453,0.022740077507997856,"['PIK3CA', 'CDIPT']",0.9997592994748913,0,0,2
510,Oxysterols derived from cholesterol WP4545,0.9466451117591476,0.41473026226389453,0.022740077507997856,"['DBP', 'SLC27A5']",0.9997592994748913,0,0,2
511,Fas ligand pathway and stress induction of heat shock proteins WP314,0.9471315832114002,0.46645595432300163,0.025336603762971532,"['CYCS', 'FADD', 'ACTG1']",0.9997592994748913,0,0,3
512,Notch Signaling WP268,0.9537666184696038,0.45228384991843396,0.021409431426737752,"['PSEN2', 'DTX4', 'DLL3']",0.9997592994748913,0,0,3
513,Complement and Coagulation Cascades WP558,0.9541417398118713,0.39810843864655526,0.018688422088957574,"['CLU', 'KLKB1']",0.9997592994748913,0,0,2
514,Neovascularisation processes WP4331,0.9541417398118713,0.39810843864655526,0.018688422088957574,"['NFKB1', 'MAPK3']",0.9997592994748913,0,0,2
515,Oxidation by Cytochrome P450 WP43,0.9541417398118713,0.39810843864655526,0.018688422088957574,"['CYB5R1', 'CYB5R3']",0.9997592994748913,0,0,2
516,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.9554546790147616,0.3111246943765281,0.014177313932954884,['MAPK3'],0.9997592994748913,0,0,1
517,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.9554546790147616,0.3111246943765281,0.014177313932954884,['PPARG'],0.9997592994748913,0,0,1
518,Ciliopathies WP4803,0.9597880838690634,0.6785714285714286,0.027850447582186084,"['DYNC2H1', 'C2CD3', 'ARL6', 'ARL3', 'WDR19', 'LCA5', 'CCDC28B', 'GLI3', 'TTLL5', 'RSPH1', 'NME7', 'CSPP1', 'TTC21B', 'TMEM107', 'BBS9', 'RAB28', 'CEP41', 'IFT57', 'DNAI1']",0.9997592994748913,0,0,19
519,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.960049159336742,0.5074135776759684,0.020687651499589815,"['CDKN1B', 'ROCK2', 'ERBB4', 'TMSB4X', 'SOD1']",0.9997592994748913,0,0,5
520,Zinc homeostasis WP3529,0.9606240667264274,0.38276521684593434,0.01537649643034681,"['SLC39A7', 'SLC39A1']",0.9997592994748913,0,0,2
521,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.962908929091446,0.2927992712977612,0.011066770574095964,['ACOX1'],0.9997592994748913,0,0,1
522,Purinergic signaling WP4900,0.962908929091446,0.2927992712977612,0.011066770574095964,['GNAI2'],0.9997592994748913,0,0,1
523,Wnt signaling pathway and pluripotency WP399,0.9683043643472125,0.552150024973891,0.017784098088636652,"['SOX2', 'MAPK10', 'WNT10B', 'CCND2', 'CCND1', 'PPP2R2B', 'PRKD1', 'NKD1']",0.9997592994748913,0,0,8
524,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.9691161366320608,0.2765100063388572,0.008674346253004157,['MAP1LC3A'],0.9997592994748913,0,0,1
525,NAD+ biosynthetic pathways WP3645,0.9691161366320608,0.2765100063388572,0.008674346253004157,['QPRT'],0.9997592994748913,0,0,1
526,DNA IR-damage and cellular response via ATR WP4016,0.9710325260233347,0.5270969498910676,0.01549418024637425,"['UPF1', 'FEN1', 'MRE11', 'PCNA', 'USP1', 'ATRIP', 'MCPH1']",0.9997592994748913,0,0,7
527,One-carbon metabolism and related pathways WP3940,0.9732614762509396,0.4032560292756051,0.010929246889419635,"['GPX4', 'CDO1', 'SOD1']",0.9997592994748913,0,0,3
528,Kit receptor signaling pathway WP304,0.9768126371772813,0.4323346282794955,0.010142751504364791,"['STAT1', 'MITF', 'HRAS', 'MAPK3']",0.9997592994748913,0,0,4
529,Heart Development WP1591,0.978588756920468,0.24881825590872045,0.005385369864081248,['BMP2'],0.9997592994748913,0,0,1
530,Prostaglandin Synthesis and Regulation WP98,0.9787840868675469,0.331621144177198,0.007111351911997373,"['MITF', 'PPARG']",0.9997592994748913,0,0,2
531,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.9797884136987863,0.38251348977286986,0.007810403336835689,"['HSP90AA1', 'CCND1', 'BAX']",0.9997592994748913,0,0,3
532,Type 2 papillary renal cell carcinoma WP4241,0.9818587650763778,0.32089738700472104,0.005874926697224137,"['ELOB', 'ELOC']",0.9997592994748913,0,0,2
533,Nanoparticle triggered autophagic cell death WP2509,0.9821725002720867,0.23695036286723328,0.004262339866695297,['MAP1LC3A'],0.9997592994748913,0,0,1
534,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.9821725002720867,0.23695036286723328,0.004262339866695297,['CCND1'],0.9997592994748913,0,0,1
535,"GPCRs, Class A Rhodopsin-like WP455",0.9847128451678033,0.502935653577359,0.007747828384627011,"['OPRD1', 'CHRM1', 'GPR22', 'NPY1R', 'PRLHR', 'NMBR', 'HTR5A', 'ADRA2A']",0.9997592994748913,0,0,8
536,Fluoropyrimidine Activity WP1601,0.9851565424346276,0.22616136919315402,0.0033821808801549253,['CES2'],0.9997592994748913,0,0,1
537,MTHFR deficiency WP4288,0.9851565424346276,0.22616136919315402,0.0033821808801549253,['CYCS'],0.9997592994748913,0,0,1
538,Phosphoinositides metabolism WP4971,0.9868051913790153,0.3551037054299697,0.004716712380433097,"['PIK3CA', 'PLCB1', 'SBF2']",0.9997592994748913,0,0,3
539,TGF-beta Signaling Pathway WP366,0.9889157554679524,0.5300041313778145,0.005907496282599129,"['TGFBR3', 'CDC42', 'KLF11', 'CCND1', 'SUMO1', 'SMURF1', 'STRAP', 'WWP1', 'RAC1', 'RUNX2', 'SKP1']",0.9997592994748913,0,0,11
540,ESC Pluripotency Pathways WP3931,0.9901040463227828,0.47854023367684057,0.0047591994260619205,"['WNT10B', 'AKT3', 'GAB1', 'BRAF', 'MAPK6', 'FGF12', 'HRAS', 'FGFR2']",0.9997592994748913,0,0,8
541,Nephrotic syndrome WP4758,0.9903664925479823,0.2841302195562285,0.002750440154481789,"['ARHGDIA', 'TTC21B']",0.9997592994748913,0,0,2
542,Ethanol effects on histone modifications WP3996,0.9914325736621002,0.19897310513447433,0.001712031791739929,['AHCY'],0.9997592994748913,0,0,1
543,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.9956883270028063,0.24851202609050144,0.0010738192382470967,"['PMVK', 'TM7SF2']",0.9997592994748913,0,0,2
544,Lung fibrosis WP3624,0.995882916606392,0.17147233229351094,0.0007074231531265754,['FAM13A'],0.9997592994748913,0,0,1
545,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.996333992192376,0.24243087110854802,0.0008903865473465954,"['MAP1LC3A', 'WIPI2']",0.9997592994748913,0,0,2
546,Phosphodiesterases in neuronal function WP4222,0.9983806275069594,0.21599106683918537,0.0003500535024477467,"['PDE4D', 'ADCY8']",0.9997592994748913,0,0,2
547,Male infertility WP4673,0.9997592994748913,0.2816326530612245,6.77972872282851e-05,"['NANOS1', 'DDX4', 'UBE2B', 'CDC42BPA', 'CLU']",0.9997592994748913,0,0,5
